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Musculoskeletal diseases (MSD) and related disorders account for the largest fraction of 
temporary and permanent disabilities, and are often considered to be an inevitable 
consequence of aging. In developed countries, these diseases are responsible for more than 
half of all chronic conditions suffered by people over the age of 50. In particular, 
osteoarthritis (OA) is among the leading causes of chronic MSD and the most common joint 
disorder in the EU. To maintain a normal active lifestyle for patients suffering from OA, the 
associated costs and the need for effective treatments are very high. For example, more than 
45 million people in the US currently have osteoarthritis and it is also the most common joint 
disorder in EU societies. To date, there is no optimal diagnostic procedure and no permanent 
cure. OA is usually detected at the level where treatment options are very limited. Thus, the 
management of OA largely relies on controlling the pain and symptoms through medical 
therapy that involves medication and rehabilitation exercises. However, if such treatments are 
inadequate, surgical procedures are necessary e.g. osteotomy or joint replacement to relieve 
pain and increase joint functions in patients with OA. One promising option involves the 
implantation of functional cartilage grafts. These are engineered using autologous cells 
harvested from a small cartilage biopsy and cultured into porous biodegradable scaffolds. 
Nevertheless, tissue engineered cartilage (TEC) is not used in routine clinical practice 
because of the variability of the tissue properties (e.g. using cells from different donors) and 
lack of reliable quality controls. The above mentioned issues generally stem from a limited  
mechanistic understanding of cartilage function. This has been driving impetus of this work 
to seek deeper fundamental insight into the functional properties of cartilage and the 
development of OA. By integrating state-of-the-art technologies, the overarching objective of 
this MD-PhD is to obtain a biomechanical assessment of the extracellular matrix in native 
and TEC spanning from the molecular length scale to the tissue level.   
 
1.1 Articular Cartilage Structure and Composition 
 
Hyaline articular cartilage (AC) is a 1-3mm thick connective tissue covering the end of the 
long bones in diarthrodial joints. In general, cartilage is a complex structure composed from 
fluid and a solid phase. The fluid phase, which is composed of water and electrolytes as the 
most prevalent components, accounts for 60-80% of the cartilage structure measured by wet 
weight. The solid phase is extracellular matrix that consists primarily of collagen II fibrils 
(~15-20% by wet weight), proteoglycans (PG) (~10% by wet weight) and chondrocytes (1-
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5%). The arrangement and distribution of these components across/within the cartilage depth 
is not uniform. Depending on the specific pattern of collagen orientation and amount of 
collagen, PG and water, cartilage can be divided into four zones: superficial, intermediate, 
radiate and calcified. The superficial zone which accounts for 20% of the full cartilage 
thickness is characterized by a high concentration of densely packed collagen fibrils that are 
oriented parallel to the joint surface, flattened chondrocytes (Figure 1.1) and relatively low 
amounts of PG. Therefore, the superficial zone exhibits the highest tensile and shear strength 
of the cartilage. The direct contact of the superficial zone with the synovial fluid has a 
significant impact on cartilage function and maintenance. Deterioration of the superficial 
zone considerably alters cartilage mechanical properties which may result in the development 
of osteoarthritis (OA). This zone has a unique function in filtering large proinflammatory 
macromolecules present in the synovial fluid, thus protecting the cartilage from immune 
reactions [1]. The intermediate zone (40-60% of cartilage thickness) has the highest amount 
of PG, randomly orientated collagen fibrils and round chondrocytes, while in the radiate zone 
(20-30% of cartilage thickness) collagen fibrils are oriented perpendicular to the underlying 
bone. Finally, the calcified zone is partially mineralized and acts as transition between 
cartilage and subchondral bone [2, 3]. The distribution of the fluid phase depends mainly on 
the PG concentration which determines the swelling pressure and collagen network strength 
and organization. In this manner, specific and complex architecture of articular cartilage 
ensures its durability and optimal function over long period of time and activity.  
1.1.1 Collagen 
Cartilage consists of specific sets of collagen such as collagen II, collagen IX and collagen XI 
[4]. The most prevalent is collagen type II which accounts for 90-95% of collagen in cartilage 
[5]. The highest concentrations of collagen IX and collagen XI are associated with thin 
collagen II. There is evidence that collagen XI acts as a template to constrain the lateral 
growth of collagen II fibrils [6] and therefore plays a role in regulating the collagen fibril 
diameter. Collagen IX decorates the surface of collagen II and plays a role in the covalent 
binding between collagen II fibrils, collagen IX and PGs. Both collagen IX and  XI contribute 
significantly to the compressive properties and long term stability of articular cartilage [7]. 
Collagen type II, together with collagen type XI are designated as fibril-forming collagens. 
Synthesis of collagen II fibers originates in chondrocytes from collagen precursor 
procollagen, which is a homotrimeric molecule composed of three distinct domains:  a N-
teminal propeptide, a central triple-helical collagenous domain and a C-terminal propeptide. 
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Figure 1.1: Cross section cut through the cartilage thickness. The foreground illustrates orientation of 
collagen fibrils “leaves” across the thickness. The background shows four distinct zones through the depth of 
cartilage, From Mansou, 2003. 
 
During the later phase of collagen maturation, procollagen matrix metalloproteinases cleave 
N- and C-terminal propeptide of procollagen (Figure 1.2) which results in the formation of 
280nm long and 1.3nm in diameter, rod-like structure known as tropocollagen. Each 
tropocollagen molecule is stabilized through intra and intermolecular crosslinking. However, 
these bonds are at this stage immature and weak.  
In the process of fibrillogenesis, tropocollagen sub-units arrange into a staggered array of 
structures with distinct 67nm banded axial repeat as observed by the electron microscope [8] 
through lateral and longitudinal interactions At this stage of fibrillogenesis, collagen 
microfibrils of up to approx. 50nm of diameter are formed. Finally, in the slow process of 
cross-linkage, collagen fibrils assemble into the collagen fibers which exhibit large diameter 
(up to 500nm) and increased tensile strength. An important role of collagen XI, collagen IX, 
decorin and other factors in collagen II fibrillogenesis has been reported [9, 10]. However, an 
alignment, undulation and twist which are present at a suprafibrillar level of in vivo collagen 
II fibrillogenesis is still not possible to engineer in vitro since the underlying complex 
mechanisms are not yet well understood. 
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Figure 1.2: Collagen fibrillogenesis. From Holmes, 2001 
 
For this reason, tissue engineered cartilage grafts primarily contains an immature form of 
collagen II, usually at the stage of microfibrils (Loparic et at. unpublished). 
Interestingly, the diameter of collagen fibers significantly increases from superficial zone 
towards the radial zone of cartilage. From an engineering point of view, a firm collagen 
network exhibits high tensile and shear strength but poor compression resistance properties 
[11, 12]. It functions as a natural scaffold in the cartilage where it regulates the shape and the 
bulk mechanical properties of cartilage. Chondrocytes are cells responsible for maintaining of 
the collagen meshwork. It is important to note, that once skeletal growth ceases, collagen is 
synthesised at a very low rate (e.g. estimated turnover time is 400 years for human femoral 
head cartilage) [13]. This has a tremendous impact on the healing capacity of the cartilage in 
the case of a degenerative disease or injury. Moreover, quantitative and qualitative changes in 
the collagen occur with age due to the higher crosslinking by advanced glycation end 
products and formation of the stabilized form of collagen [14, 15]. These changes result in 
increased mechanical strength, brittleness, denaturing temperature and higher conversion of 
soluble to insoluble forms of collagen which make the cartilage more prone to develop 
osteoarthritis (OA) [16]. In the early phase of OA the collagen network is not significantly 
affected as the PGs whilst with further development of OA, concentration of collagen 
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degrading enzymes (e.g. matrix metalloproteinase - MMP or collagenase) is increased, 
particularly MMP-1 and MMP-13. These enzymes start to extensively disrupt collagen 
molecules and overall meshwork and this is considered as the beginning of advanced or 
irreversible phase of OA. Then the healing capacity of cartilage as well as medical treatment 
is very limited. Altered mechanical properties of collagen tremendously affect the cartilage 
shape, integrity and function. Numerous techniques have been employed to measure the 
mechanical properties of macroscopic collagen fibers (e.g. diameter of few hundred of nm) 
[17-19] and tropocollagen molecules (diameter approx 1.33nm) [20, 21]. However, the 
mechanical properties of both microfibrilar and fibrilar collagen (e.g. diameter from 20 nm to 
over 100 nm) are beyond the scope of these techniques. The introduction of the Atomic Force 
Microscope (AFM) bridges this gap to assess the mechanical properties of collagen at 
microfibrilar, fibrilar but also fiber structural levels [22] Moreover, since microfibrilar 
collagen is produced in engineered cartilage, the AFM provides a better understanding of the 
collagen and TEC mechanics. In this way, AFM is also a valuable quality control tool.  
 
1.1.2 Proteoglycans 
The major structural component of PG is an aggrecan monomer. It has a bottle-brush 
architecture and consists of a core protein (CP) with many covalently bonded 
glycosaminoglycans (GAGs) side chains, predominantly chondroitin (CS) and keratane 
sulphate (KS) (Figure 1.3). Multiple aggrecan monomers are non-covalently bound to 
hyaluronic acid (hyaluronan) which form a concentrated space-filling gel that ensures 
aggrecan retention within the collagen network [23]. The binding between the aggrecan and 
hyaluronan is additionally stabilized by a link protein [24, 25].  
PG concentration is not uniform across cartilage tissue and increases towards the cartilage 
bone interface. The low concentration of PG on the cartilage surface is more permeable to 
fluid flow which plays an important role in a cartilage compression resistance. One distinct 
property of the aggrecans is the high fixed negative charge density which originates from 
numerous anionic sulphate (SO3
-
) and carboxyl (COO
-
) groups across GAG side chains. The 
fixed negative charges contribute to the polyelectrolytic character of the aggrecans where he 
charged state of anionic groups is regulated according to the pH and salt concentration of the 
surrounding solution. In high salt concentrations, the fixed negative charges are saturated 
with counter ions that reduce the repulsive electrostatic force between charged side chains 
and tend to a collapse of the whole aggrecan monomer (Figure 1.4.). 
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Figure 1.3: Scheme of aggrecan molecule and the proteoglycan aggregates of aggrecan and hyaluronic 
acid. CP: core protein, CS: chondroitin sulfate, and KS: keratan sulfate. The G1, G2, and G3 are globular 
domains. From Ng,. 2003 
 
In contrast, in low salt concentrations most of the fixed negative charges are exposed and the 
repulsive forces between them drive the whole aggrecan monomer to become fully extended 
(Figure 1.4). Moreover, the fixed negative charges cause in the counter ions imbalance that 
finally results in the high osmotic pressure within the PG. The resulting swelling of the PG 
gel is counteracted by the firm collagen network that, together with the high concentration of 
aggrecan aggregates, is responsible for the low permeability of the ECM.  
 
 
Figure 1.4: Influence of a buffer ionic strength on PGs morphology and mechanics 
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The resistance to fluid flow (friction drag), is a result of the low permeability which is a 
crucial component in dissipating energy from the loaded cartilage explained below.  
Another class of PGs includes smaller molecules like decorin, biglycan and fibromodulin 
[26]. Aggrecan is synthesised and secreted by chondrocytes but at much higher rates 
compared to the collagen thus improving its healing capacity in case of injury or degenerative 
disease. However, a loss of cellularity of chondrocytes together with non-enzymatic age 
related modifications has a significant impact on the aggrecan performance in the mechanical 
function of cartilage [15].  
During aging and degeneration PGs undergo significant alterations in composition and 
organization with respect to both core protein and aggrecan size, sulphate pattern 
modification and to the length of CS and KS side chains [27-29]. Two different mechanisms 
are involved in the age-related modifications of PGs. In the first, different 
glycosyltransferases and sulfotransferases are involved in modifications of GAG chains and 
are major factors in determining the size and composition of GAGs [30]. For example, 
significant changes during aging are found in the increase of 6-sulphated form of CS (C6S) in 
comparison to the 4-sulphated form (C4S). The ratio C6S to C4S dramatically raises from the 
stage of fetal, immature cartilage (<1) to the adult, mature cartilage (>20) [31]. Moreover, it 
was found that a disulphate  form of the CS, chondrotitin-4,6-sulphate, plays an important 
role in chain length control by reducing its synthetic activity in chondrocytes [32]. KS chains 
are becoming longer and the CS shorter during lifetime what may be the results of an 
avascular nature of cartilage and consequently impaired oxidation of glucose to glucuronic 
acid needed for CS synthesis [33]. However, its effects on altering cartilage function are still 
under debate. A second key mechanism of the age related GAGs modification stems from the 
shortening of the aggrecan monomers due to the proteolytic cleavage at its both ends [34]. 
This process is modulated by chondrocytes and executed predominantly by ADAMTS-4/5 
and MMP activity where after release, the specific fragments of the aggrecan monomers are 
accumulated. Moreover, those fragments are in competition with de novo synthesised intact 
aggrecan monomers, which has an impact on the overall aggrecan concentration. A relative 
slow turnover of the fragments prolongs the effect on the ordered assembly and stability of 
the aggrecan with aging. In case of injury an involvement of the different proinflammatory 
factors (e.g. IL-1β, TNF-α, TNF-β) enhance the proteolytic cleavage of aggrecan and tends to 
a dramatic deterioration of the aggrecans and the whole cartilage.   
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Interestingly, aggrecans are not as stable as the firm collagen network and are more easily 
affected by degenerative diseases. A degradation of aggrecans at the onset of the degenerative 
diseases results in a decrease of cartilage stiffness. This can be potentially used as a new 
biomarker in detecting the degeneration of cartilage. Nevertheless, a reduction of aggrecans 
and subsequently cartilage stiffness can be overshadowed by the higher stiffness of the 
surrounding collagen network. In this regard, the Atomic Force Microscopy represents a 
valuable tool with sufficiently high sensitivity, at the nanometer scale stiffness measurement, 
to determine the contribution of aggrecans, typically located in-between collagen fibers, to 
cartilage stiffness. Conventional methods such as histology, immunohistochemistry and 
western blot require more demanding preparation protocols and yet lack the sensitivity and/or 
specificity to discriminate between each component. 
 
1.2 Cartilage function 
AC forms a mechanically resilient tissue exhibiting remarkable load-bearing properties - it 
withstands compressive forces that can be several times the weight of the body without 
damage over several decades of life. In addition to its resistance to compression, a cartilage 
surface exhibits excellent tribology properties which together with synovial fluid promote the joint 
motion with minimal friction and wear [3]. 
 
1.2.1 Load-bearing properties of cartilage 
The remarkable load-bearing properties of cartilage result from the poroviscoelastic nature of 
ECM which stores and dissipate energy. Cartilage is considered as a biphasic composite 
material composed from a solid matrix and an interstitial fluid phase. The main viscoelastic 
response of the cartilage comes from the friction drag which is occurs as the interstitial fluid 
phase is squeezed phase and flows through the low permeable solid phase (flow dependant 
viscoelasticity) [35]. Interestingly, under impact loads cartilage behaves as a single-phase, 
incompressible, elastic material where interstitial fluid comprising of water, electrolytes and 
nutrients can withstanding over 90% of the load support [36]. Another minor contribution 
originates from the intrinsic viscoelasticity of the solid matrix (flow independent 
viscoelasticity) [37] based on the formation and breaking of temporary bonds between solid 
phase molecules [38]. The porous solid phase is composed from the fibrilar collagen II 
network, highly negatively charged proteoglycan gel and the chondrocytes [39]. Aggrecans, 
major PGs in cartilage, are incorporated into a dense collagen meshwork. Large anionic GAG 
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side chains of aggrecans attract counter-ions (e.g. Na
+
, Ca
+
) which generates an extremely 
high osmotic pressure known as the Donnan effect [40]. Finally, the high osmotic pressure 
creates a large flow of water into the ECM of cartilage thus maintaining the cartilage 
hydration. The addition of water generates swelling and expansion of the aggrecans within 
the firm collagen network. An equilibrium state is achieved when the swelling force is 
insufficient for further stretching of the collagen network (Figure 1.3). This gives cartilage an 
excellent compression resistance property since loading “squeezes” aggrecans which increase 
the repulsive forces in-between fixed negative charges and places collagen network under 
further tension. A subsequential removal of the load leads to a redistribution of water and 
restitution of pre-load equilibrium state [41]. Thus, articular cartilage is a tough but compliant 
load-bearing tissue with mechanical characteristics that depend on the integrity of the 
collagen network and the concentration of embedded PGs. 
 
 
 
Figure 1.5: Compression resistance mechanism of the collagen/aggrecan network. From Mow, 1994 
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1.2.2 Frictionless Articulation 
 Various physiochemical mechanisms have been proposed to explain the superb lubrication 
and wear characteristics of cartilage. These include fluid-film lubrication[42], boundary 
lubrication [43, 44], mixed lubrication (e.g. weeping lubrication[45], boosted lubrication[46], 
and the interstitial fluid pressurization[47]). Fluid-film lubrication considers the presence of a 
thick layer of synovial  fluid in between the opposing surfaces [48]. The fluid in this confined 
layer is pressurized by an applied load which prevents a direct contact of bearing surfaces so 
as to minimize friction and wear are minimized. However, this theory is in contradiction with 
experiments conducted by McCutchen [45, 49] who observed that the friction coefficient of 
the cartilage did not return to the initial value within one second after unloading as it is 
expected in the case of a fluid-film regime in a confined space. Therefore, McCutchen 
proposed the mechanism of mixed lubrication, more precisely weeping lubrication theory as a 
better explanation of cartilage lubrication mechanism. In the weeping lubrication theory, 
under the loading condition a pressurized interstitial fluid flows out into the space between 
opposing load bearing surfaces and forms a thick film of lubricant. A “weeping” of the 
interstitial fluid through the porous wall supplies enough liquid to maintain the film [49]. 
Interestingly, the opposing bearing surface layers within the joint create the contact over a 
10% of the total area where a direct surface-to-surface friction occurs [50]. Thereby, a 
boundary lubrication regime is present here and it involves several molecules, such as 
hyaluronan [51] , PRG4 (i.e. lubricin, superficial zone protein, and megakaryocyte-
stimulating factor) [52] and surface-active phospholipids [53]. These molecules are present in 
both the synovial fluid and on the cartilage surface in order to protect and maintain the 
cartilage surface. Moreover, a fluid film at the cartilage surface can contribute to bearing up 
the load [54]. Consequently, disturbances of the lubrication molecules clearly have a 
significant impact on both lubricative and load-bearing properties of the cartilage which  
could result in the onset of cartilage diseases, including osteoarthritis. 
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Figure 1.6: Concept of mixed lubrication regime. From Kelly, 1998 
 
1.3 The Pathophysiology of Articular Cartilage 
Cartilage is an avascular, aneural and alymphatic tissue [26]. An oxygen gradient from the 
synovial surface towards hypoxic deep zone (pO2 ~ 2–5%) [55] is present. Synovial fluid and 
subchondral capillaries provide the nutrition for the chondrocytes. The diffusion of interstitial 
fluid through the matrix during cyclic loading of the cartilage tissue supplies the nutritions 
and removes waste products from chondrocytes. Chondrocytes maintain ECM integrity in a 
low-turnover anabolic/catabolic state of equilibrium which is altered in case of aging and 
trauma in favour of catabolic activity responsible for cartilage degradation. The absence of 
blood vessels and small amount of chondrocytes (1-5%), whose number and metabolic 
activity declines with age [56, 57] can cause the limited healing capacity of cartilage in the 
event of injury or degenerative diseases. Moreover, once initiated, this damage tends to mark 
the onset of degenerative diseases such as OA, which is affecting 80% of the elderly 
population. In the advanced stage cartilage is thinned, and eventually completely worn out 
with bones rubbing directly against each other. Furthermore, OA is characterised by a 
subchondral bone sclerosis, formation of osteophytes and modification of the synovial fluid 
composition. The quality of life is significantly reduced due to the resulting pain, reduced 
mobility and working disability. Unfortunately, OA disables two to three times more workers 
than all other chronic conditions.  Currently, there is a variety of treatments in clinical use for 
the repair and regeneration of chondral and osteochondral defects in the knee or hip joints 
(e.g. microfractures, autologous chondrocyte transplantation, biodegradable scaffolds) [58-
60], but none of these is able to durably restore the complex hyaline structure and function of 
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native cartilage [61]. One of the reasons why TEC has not yet been introduced in the routine 
clinical practice is related to the variability of the tissue properties achieved using different 
protocols and the lack of reliable quality controls. Another major issue related to the onset of 
osteoarthritis is a lack of the early diagnostic tool which will be able to detect inception of the 
OA, at the level where treatment options are much more efficient than in a more advanced 
stage of the disease. Currently available diagnostic techniques (e.g. X-ray, MRI, arthroscopy, 
ultrasound) lack both the sensitivity and specificity for early detection of the OA. For 
development of early diagnostic methods and design of a functional engineered cartilage 
constructs it is essential to first understand the structure-function relationships of natural 
articular cartilage. Since cartilage mechanics is primarily determined at the molecular level, 
emerging field of cartilage nanomechanics is offering a great potential to revel new scientific 
information about the cartilage tissue mechanics and in particularly the structure-function 
relationship. The origin of cartilage nanomechanical properties can be traced to the molecular 
scale, thus providing the link between OA and the molecular origins of cartilage deformation 
and degeneration. This is important since the morphological and biomechanical changes 
(mechanical properties including stiffness, dynamic load etc) at the onset of the disease are 
accurately detectable at the nanometer (molecular) scale and can be used as a powerful tool to 
validate simulation results in terms of predicting the progression stages of OA disease.  
 
 
1.4 Assessment of Articular Cartilage 
The traditional approach involves visual inspection and histology [37-38], optical microscopy 
[39] and allow for direct in vitro observation of cartilage. Applying electron microscopy [40-
41] reveals ultra-structural details at molecular resolution. Visual inspection, histology and 
optical microscopy are limited in terms of spatial resolution (i.e. ~200 nm) to resolve 
nanometer scale features. Electron microscopy requires chemical fixation and dehydration of 
the cartilage, followed by metal staining or sputtering, so the specimen is no longer in its 
native state. Other disadvantages of electron microscopy are the complexity and prolonged 
time requirements of the sample preparation procedures. Moreover, neither light nor electron 
microscopy can directly measure the cartilage’s mechanical properties. Another imaging 
method is the MRI – a non-invasive method capable of directly visualizing the articular 
cartilage macro-morphology i.e. volume and thickness in situ. However, cartilage due to the 
relatively short transverse relaxation time (T2) and broad range of potential sources of 
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artefacts presents a significant challenge for imaging when using MR technique [45]. 
Moreover, even state-of-the-art MRI modes e.g. the 3D water-excitation true FISP MRI 
allows assessment of the knee`s articular cartilage abnormalities with moderate-to-high 
specificity and low-to-moderate sensitivity [46]. The most direct method for measuring 
cartilage stiffness is by compression testing. This requires specimens to be precisely oriented 
in parallel (opposing top and bottom surfaces), what can be only achieved by cutting the 
cartilage off the bone and trimming the specimens. Since indentation testing avoids cutting, 
numerous indentation testing devices have been employed to measure the quality of “healthy 
vs. diseased” articular cartilage [42-43]. These devices employ indenters with typically 1-2 
millimetre tip diameter. However these are unable to resolve molecular-level differences in 
the cartilage specimen.  
 
1.4.1 Nanomechanics of Cartilage 
Nanomechanics of cartilage is an emerging filed based on applying the atomic force 
microscopy to determine the mechanical properties of cartilage at the molecular level. In 
contrast to other indentation testing devices, AFM has the ability to assess the biomechanical 
properties of cartilage across length scales in close to native conditions (Chapter 2). Over the 
last decade AFM has been established as a powerful tool capable of simultaneously imaging, 
manipulating and measuring the mechanical properties of native biological tissues at the 
micrometer to nanometer scale [47]. An unprecedented advantage of the AFM over other 
indentation testing devices is that very small biological specimens (radius 500µm or more), 
ranging from tissues to cells and molecules, can be investigated in near physiologic 
conditions (e.g. 37° C, physiological buffer, gas controlled environment, non fixed or stained 
sample) [48].  
The other advantage of the AFM as compared to the MRI is that it is sensitive to surface 
changes at the nanometer scale. This is where matrix degeneration generally begins in the 
superficial cartilage and then progresses to the deeper regions of the tissue [49]. Two 
methods can be applied for measuring mechanical properties by AFM. IT AFM which is used 
to examine structure–function relationships of cartilage at both micrometer and nanometer 
scales [49]. Micrometer scale measurements are limited to revealing only the chondrocytes 
and the surrounding ECM (Loparic et al. in preparation). This results in a unimodal 
distribution of the stiffness since the bulk elastic property of the ECM is probed. In contrast, 
nanometer scale measurements give rise to a bimodal distribution of the measured stiffness. 
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These two peaks correspond to the stiffness of the molecular constituents of cartilage 
(collagen II and proteoglycans) [62]. Clearly, IT AFM provides a good basis for assessing the 
structure–function relationships of normal, diseased and tissue engineered cartilage. 
Moreover, when compared to the MRI technique, IT AFM is able to resolve all grades of the 
cartilage osteoarthritis disease (Outerbridge scale system) in the human knee joint [33]. As 
compared to the sensitivity of AFM to the cartilage surface region, MRI has a spatial 
resolution of ~ 200 µm (e.g. for 7T MRI resolution) which limits its access to regions close to 
the cartilage surface (thickness ~ 100µm). Thus, AFM studies are particularly important in 
early detection of abnormalities of cartilage since matrix degeneration generally begins in 
superficial cartilage. Second method, the FF AFM measurement targets the lubricin-friction 
relationships in the cartilage [51] which is of particular importance in understanding the onset 
and progression of the OA. Lubricin is the main protein responsible for regulating the friction 
properties of cartilage and has important role in the development of the OA [52]. 
Additionally, by applying the AFM for nanometer scale imaging of the native cartilage it is 
possible to reveal fine structural details (e.g. collagen fibrils orientation and surrounding 
proteoglycans moiety) not resolved by other techniques [62]. Finally AFM techniques have 
great potential for the understanding the molecular mechanisms driving the onset of OA and 
thus to predict, the patient-specific characteristics of articular cartilage, specifically after 
osteotomy surgery.  
In this thesis, biomechanical properties of ECM matrix and its major components from native 
and tissue engineered cartilage have been measured. Nanoscale resolution of AFM-based 
technique allows us for the first time measurement of the individual mechanical properties of 
cartilage's soft PG gel and the collagen fibrils and their contribution to cartilage stiffness 
measured at the micrometer scale (Chapter 2). Next we proposed and validated a quantitative 
AFM-based functional analysis to evaluate the influence of various biomechanical stimuli on 
quality of engineered cartilage grafts (Chapter 3). In particular, we demonstrated that the 
sliding-type biomechanical stimulus, similar to physiological articulation, plays an essential 
role in superior tribological and load bearing properties of engineered cartilage grafts. In 
addition, we measured the mechanical properties of cartilage grafts obtained from animal 
donors undergoing gene therapy procedure where genetically modified bone marrow clots 
were used to repair defect sites with or without the presence of growth factors. (Chapter 4). 
We indentified different amounts and spatial orientation of newly synthesized extracellular 
components and/or water content within the repaired tissue and compare these values to ones 
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measured in the native cartilage. In the next work, we proved that the application of more 
physiologic oxygen percentage (5 % O2) during specific phases of differentiation culture of 
HAC enhanced the biosynthetic activity and reduced the activity of catabolic enzymes 
implicated in cartilage breakdown (Chapter 5). Last but not least, by operating AFM in the 
torsional mode on individual collagen fibers isolated from native cartilage we measured 
mechanical response at the molecular level directly related to their fundamental physical 
characteristics: persistence and contour length, adsorption strength (Chapter 6). Overall, work 
presented in this thesis demonstrates the potential use of cartilage nanomechanics as a 
valuable marker for assessing the functionality of native and tissue engineered cartilage 
thereby fostering pre-symptomatic diagnostics and treatment. 
 
 
1.5 Abbreviations  
ECM: extracellular matrix; EM: electronic microscopy; GAG: glycosaminoglycans; HAC: 
human articular chondrocytes; MMP: metalloproteinase; OA: osteoarthritis; PBS: phosphate 
buffered saline; SEM: scanning electron microscopy; TEM: transmission electron 
microscopy; TGFβ1: transforming growth factor beta-1. AFM: Atomic Force Microscopy; 
PG: Proteoglycan; FF AFM: Friction Force AFM; IT AFM: Indentation-type AFM; MRI: 
magnetic resonance imaging; FISP MRI: fast imaging with steady state precession magnetic 
resonance imaging; IL-1β: interleukin-1β; TNF-α: tumor necrosis factor alpha, TNF-β: tumor 
necrosis factor beta; ADAMTS: a disintegrin and metalloproteinase with a thrombospondin; 
CS: chondroitin; KS: keratane sulphate;  
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Chapter 2: Stiffness measurements of native articular cartilage across scales 
2.1 Abstract 
As documented previously, articular cartilage exhibits a scale-dependent dynamic stiffness 
when probed by indentation-type atomic force microscopy (IT-AFM). In this study, a 
micrometer-size spherical tip revealed an unimodal stiffness distribution (which we refer to 
as microstiffness), whereas probing articular cartilage with a nanometer-size pyramidal tip 
resulted in a bimodal nanostiffness distribution. We concluded that indentation of the 
cartilage's soft proteoglycan (PG) gel gave rise to the lower nanostiffness peak, whereas 
deformation of its collagen fibrils yielded the higher nanostiffness peak. To test our 
hypothesis, we produced a gel-microfiber composite consisting of a chondroitin sulfate-
containing agarose gel and a fibrillar poly(ethylene glycol)-terephthalate/poly(butylene)-
terephthalate block copolymer. In striking analogy to articular cartilage, the microstiffness 
distribution of the synthetic composite was unimodal, whereas its nanostiffness exhibited a 
bimodal distribution. Also, similar to the case with cartilage, addition of the negatively 
charged chondroitin sulfate rendered the gel-microfiber composite's water content responsive 
to salt. When the ionic strength of the surrounding buffer solution increased from 0.15 to 2 M 
NaCl, the cartilage's microstiffness increased by 21%, whereas that of the synthetic 
biomaterial went up by 31%. When the nanostiffness was measured after the ionic strength 
was raised by the same amount, the cartilage's lower peak increased by 28%, whereas that of 
the synthetic biomaterial went up by 34%. Of interest, the higher peak values remained 
unchanged for both materials. Taken together, these results demonstrate that the nanoscale 
lower peak is a measure of the soft PG gel, and the nanoscale higher peak measures collagen 
fibril stiffness. In contrast, the micrometer-scale measurements fail to resolve separate 
stiffness values for the PG and collagen fibril moieties. Therefore, we propose to use 
nanostiffness as a new biomarker to analyze structure-function relationships in normal, 
diseased, and engineered cartilage. 
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2.2 Introduction 
Imaging methods for analyzing articular cartilage structure 
Visual inspection and histology [1-3] and optical microscopy [4, 5] allow for direct in vitro 
observation of fresh cartilage under near-physiological conditions but are limited to a spatial 
resolution of ~200 nm. In contrast, electron microscopy [6-8] reveals ultrastructural details at 
molecular resolution but requires chemical fixation and dehydration of the cartilage, followed 
by metal staining or sputtering, so that the specimen is no longer in its native state. Other 
disadvantages of electron microscopy are the complexity and prolonged time requirements of 
the sample preparation procedures. Moreover, neither light nor electron microscopy can 
directly measure the cartilage's mechanical properties. In contrast, atomic force microscopy 
(AFM) allows for simultaneous imaging and stiffness measurements on a micrometer–
nanometer scale in native samples, and thus can help elucidate the structure and mechanical 
properties of articular cartilage. 
Overview of articular cartilage structure-mechanical property relationships 
Aggrecan is the most abundant proteoglycan (PG) in articular cartilage and exhibits a bottle-
brush structure. The function of aggrecan is strongly determined by the electrostatic repulsion 
of its glycosaminoglycan side chains, which carry highly negatively charged carboxyl and 
sulfate groups that repel each other [9]. In physiological solution, the negative charges are 
balanced by an influx of positive ions (Na
+
 and Ca
2+
). This influx of ions results in an 
osmotic balance between the PGs and the surrounding synovial fluid, which in turn leads to 
the creation of a PG gel that causes cartilage to swell in physiological saline solutions. As a 
result of this swelling and the low water permeability of cartilage (10
−15–10−16 m4/Ns), under 
applied loads the resulting osmosis-based cartilage structure is poroviscoelastic, which 
enables the tissue to store and dissipate energy upon mechanical deformation [10-13]. 
 
Collagen fibrils are the other principal matrix component in articular cartilage. As a result of 
extensive covalent cross-linking, they form a very strong three-dimensional (3D) collagen 
meshwork [14, 15]. Thus, articular cartilage is a composite biomaterial consisting of two 
interpenetrating 3D components (i.e., a PG gel and a cross-linked collagen meshwork) that 
can resist compressive, tensile, and shear forces. Each individual component of this tissue 
exhibits distinct physical and chemical properties. Hence, changes in the relative amounts of 
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collagen, PGs, and water can affect the mechanical properties of cartilage, as frequently 
described in studies of cartilage pathology [11,12, 16]. 
Overview of direct mechanical determination of articular cartilage stiffness 
When tested at the micrometer–centimeter scale, articular cartilage behaves as a 
nonstructured and uniform material. This widely used first approximation allows 
measurement of the overall cartilage stiffness. Also, since cartilage is poroviscoelastic, any 
overall stiffness measurement produces an aggregate modulus, E
*
, which is the result of both 
elastic and viscous contributions to stiffness (see Fig. 4). Depending on the experimental 
loading conditions, the loading geometry employed by the articular cartilage exhibits a wide 
range of values of E
*
, from ~1 MPa when loaded at a low frequency of <0.1 Hz [12, 17] to 
~60 MPa at dynamic cyclic loads (40 Hz) [18]. At low loading frequencies, the mobile water 
moves through the pores in the PG gel in response to the load, resulting in a lowering of the 
cartilage's stiffness. In contrast, at high loading frequencies, the cartilage's low permeability 
prevents the incompressible water from being displaced, resulting in the cartilage exhibiting a 
higher stiffness. 
Articular cartilage millimeter-scale stiffness measurements 
The most direct method for measuring cartilage stiffness is compression testing; however, 
this approach requires specimens with highly parallel top and bottom surfaces, which can 
only be achieved by cutting the cartilage off the bone and trimming the specimens. In 
compression tests, one must also decide which constraints best simulate the situation in vivo 
(e.g., lateral confinement) and whether the support plate and lateral confinement should be 
porous to allow movement of water out of the cartilage at low deformation rates. Since 
indentation testing avoids the need for cutting, numerous indentation testing devices have 
been employed to measure the quality or health/disease state of articular cartilage [19-21]. 
These devices employ indenters, typically with a 1–2 mm tip diameter, to quantify the 
resistance to indentation (stiffness) in a manner similar to that used by the surgeon with a 
simple hand-held probe. Unfortunately, several investigators have reported that millimeter-
scale indenter stiffness measurements are not sensitive to even substantial changes in 
cartilage structure associated with aging or early-stage osteoarthritis [20, 22]. 
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Choosing articular cartilage dynamic loading conditions 
Stiffness tests of cartilage are often performed under displacement control. For example, a 
series of submillimeter-scale step compression or indentation displacements are applied [23]. 
In such experiments, each displacement is maintained until the resultant force decays to an 
equilibrium value. An equilibrium modulus is then determined from the slope of the resultant 
set of force/displacement values. The force decay is a viscous stress relaxation in response to 
the imposed 3D structural change, where the relaxation results from slow movement of water 
through and out of the cartilage. These measurements can take hours to accomplish. The 
equilibrium modulus is thus related to the cartilage's permeability. In contrast, during gait, the 
articular cartilage needs to respond to a much faster cyclic loading through deformation. Even 
though the loads applied to cartilage are not technically controlled by the use of feedback 
steering to maintain a constant load function, the mechanical behavior of cartilage is best 
mimicked by load-controlled cyclic deformation. Under such conditions, the low 
permeability of cartilage significantly restricts the water's mobility through the tissue. Of 
most importance for diagnostic applications in a clinical environment, the measurements need 
to be fast. Therefore, we performed indentation testing at a rate of three indentations per 
second, corresponding to loading rates similar to gait [24, 25]. 
In the context of exploring novel treatment modalities for osteoarthritis, we recently made the 
significant observation that all morphological and biomechanical changes that occur at the 
onset of this disease can solely be depicted on the nanometer scale [25]. In particular, when 
we employed micrometer-size spherical tips for indentation-type (IT)-AFM, the 
microstiffness values of articular cartilage exhibited a Gaussian distribution with a peak at 
E
*
micro = 1.3 ± 0.4 MPa [25], in good agreement with previously reported values of 
macroscopic compressive stiffness measurements obtained at similar loading frequencies 
(12). In contrast, when we mapped a cartilage surface by employing nanometer-size IT-AFM 
tips, the measured stiffness exhibited a bimodal distribution, with one peak exhibiting higher 
stiffness and one peak exhibiting lower stiffness. We assumed that the lower stiffness peak 
with values of E
*
PG ~20 kPa reflected the stiffness of the PG gel, whereas the higher stiffness 
peak with values of E
*
Col ~400 kPa reflected the stiffness of the collagen fibrils [24, 25]. In 
the study presented here, we modeled the composite nature of cartilage by creating a simple 
poly(ethylene glycol)-terephthalate (PEGT)/poly(butylene)-terephthalate (PBT)-
fibril/agarose/chondroitin sulfate model with a cartilage-like structure, and compared the 
bimodality of its nanometer-scale stiffness with that of articular cartilage. 
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2.3 Materials and Methods 
 
Cartilage sample preparation and IT-AFM measurements 
Cartilage specimens were prepared as described previously [24]. Briefly, porcine articular 
cartilage from freshly slaughtered pigs (within 1–2 h postmortem) was harvested from the 
femoral heads by cutting samples off the underlying bone with a sharp razor blade, yielding 
~5 mm × 5 mm pieces that were ~2 mm thick. The specimens were stored in phosphate-
buffered saline (PBS; 2.6 mM NaH2PO4, 3 mM Na2HPO4, 155 mM NaCl, 0.01% NaN3 w/v, 
pH 7.2) supplemented with a protease inhibitor cocktail (Complete, Boehringer Mannheim, 
Mannheim, Germany). The samples were covered with the buffer solution and stored on ice. 
After the articular cartilage topography was imaged by contact-mode AFM at a scanning rate 
of ~0.7 Hz, stiffness measurements were obtained by IT-AFM in the same buffer solution. 
Samples from three different pigs and from three different locations each were analyzed. 
 
Osmotic loading of cartilage 
The isotonic PBS solution contained 2.6 mM NaH2PO4, 3 mM Na2HPO4, 155 mM NaCl, 
0.01% NaN3 w/v, pH 7.2. The hypertonic PBS contained 2.6 mM NaH2PO4, 3 mM Na2HPO4, 
2 M NaCl, 0.01% NaN3 w/v, pH 7.2. Three cartilage samples each were tested separately. 
 
Preparation of agarose and agarose/chondroitin sulfate gels 
For exploratory calibration testing, agarose gels were prepared with 0.5%, 1.0%, 2.25%, and 
3.5% (w/w) agarose (AGAR Noble; DIFCO Laboratories, Detroit, MI) in water. For the 
model material used here, 50 mg of agarose were stirred in 10 mL of PBS, heated up until the 
solution started to boil, and then cooled down to ~50°C. Next, 200 mg chondroitin sulfate 
(chondroitin sulfate A from bovine trachea, C9819-5G; Sigma) was added and properly 
mixed, resulting in a concentration of 20 mg/mL of chondroitin sulfate in the gel. The melted 
agarose/chondroitin sulfate solution was used to prepare the specimens described below and 
to perform the swelling tests. Three gel samples were then tested in isotonic and hypertonic 
PBS. 
 
PEGT/PBT-fibril/agarose/chondroitin sulfate gel model material 
PolyActive (PEGT/PBT block copolymer; CellCoTech, Bilthoven, The Netherlands) fibrils 
were produced by means of the electro-spinning (ESP) technique [26, 27]. Briefly, the 
PEGT/PBT copolymer (1000 MW PEGT, 70% PEGT, 30% PBT) was dissolved in a mixture 
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of 10 mL dichloromethane and 10 μL distilled water, and stirred at room temperature for 24 
h. The ESP device consisted of a syringe pump (Harvard Apparatus, South Natick, MA), a 
high-voltage generator (0–30 kV; Brandenburg Ltd., South Croydon, Surrey, England) 
connected to a syringe (10 mL, 1.6 mm steel needle; Becton Dickinson, Franklin Lakes, NJ) 
containing the polymer solution, and a stainless-steel plate. An electrical field was applied 
between the needle (positive pole) and the stainless-steel plate (negative pole). A polymer jet 
from the spinneret (needle) was then collected as a nonwoven mesh of fibers onto glass 
microscopy slides (76 × 26 mm; Menzel, Braunschweig, Germany) placed on the stainless-
steel plate. ESP resulted in the production of PEGT/PBT fibers of 2.9 ± 0.19 μm thickness, as 
measured based on scanning electron microscopy images. 
A plastic ring (~3 mm inner diameter, ~0.2 mm thick, ~1 mm high) was used to mix the 
PEGT/PBT-fibrils with the agarose/chondroitin sulfate gel for testing by AFM. This ring was 
placed onto a PEGT/PBT-fiber-coated glass slide. The fibril coating around the ring was 
removed with a scalpel. Then, a droplet of ~50 μL of melted 1.0% (w/w) agarose gel was 
placed into the ring on top of the fibril mesh. For the swelling tests in this work, a droplet of 
the melted agarose/chondroitin sulfate was used instead. After solidification was achieved, 
the slide was kept in a cold room (4°C) for ~15 min. The specimen was then removed from 
the glass slide by moving the ring laterally until it and the specimen were free of the slide. 
The specimen surrounded by the ring was then glued upside down onto a 10-mm-diameter 
Teflon disk with a 5-min curing epoxy (Devcon epoxy; ITW Brands, Wood Dale, IL). The 
upside-down orientation of the specimen ensured that the surface to be evaluated by AFM 
was populated with fibrils. To prevent drying, the specimen was covered with a droplet of 
PBS. Three samples were inspected per experimental condition. 
 
AFM and indenter tips 
AFM experiments were carried out with a MultiMode AFM and NanoScope IIIa controller 
(Veeco Metrology, Santa Barbara, CA). AFM tips of different diameters were selected and 
prepared as follows: For micrometer-scale measurements, hard borosilicate glass spheres 
(9000 series glass particle size standards 2–2000 μm; Thermo Fisher Scientific, Fremont, 
CA), diameter d = 10 μm, were glued onto tipless rectangular cantilevers (type NSC12; NT-
MDT, Moscow, Russia) with nominal spring constants k in the following ranges: 6.5 N/m ≤ k 
≤ 27.5 N/m for probing cartilage, and 0.2 N/m ≤ k ≤ 0.7 N/m for probing the model material 
(Fig. 2.1 A). For nanometer-scale experiments, pyramidal tips with a nominal tip radius ≤ 20 
nm on V-shaped cantilevers with a nominal spring constant of 0.06 N/m (type NPS; Veeco) 
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were employed (Fig. 2.1 B). The spring constant was measured for each cantilever by means 
of the thermal noise method [28]. The actual diameter of each micrometer-size tip was 
determined with the use of scanning electron microscopy images. 
 
 
Figure 2.1: Cartoon showing the interaction of a micrometer-size spherical tip (A) and a 
nanometer-size pyramidal (B) AFM cantilever tip with cartilage. 
 
Stiffness measurements obtained by IT-AFM 
Measurements of micro- and nanostiffness (dynamic aggregate modulus, E
*
) were obtained 
by IT-AFM as described previously [24]. Briefly, maps of load-displacement curves were 
recorded in a regular grid over the sample surface by employing the force-volume mode. An 
individual set of data consisted of 4096 load-displacement curves obtained at a rate of three 
full loading cycles per second in a 64 × 64 curve grid covering sample areas of ~15 μm × 15 
μm. Each force curve consisted of 512 data points. For microscale measurements, a 
maximum deflection of 150 nm was chosen, which corresponded to a maximum applied load 
of ~2.0 μN for the cartilage measurements (with k = 13.5 N/m) and a maximum applied load 
of ~105 nN for the model material (with k = 0.7 N/m; d = 7.7 μm). For nanoscale 
measurements, a maximum deflection value of 30 nm was set, resulting in a maximum 
applied load of ~1.8 nN (with k = 0.06 N/m) to probe both authentic articular cartilage and 
the model material. 
 
Stiffness data acquisition and calculations 
Stiffness values for cartilage and the model material were obtained from IT-AFM unloading 
curves. The use of data from unloading (rather than loading) curves ensures that the 
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displacement data do not contain any irreversible (e.g., plastic) deformation or other 
extraneous displacement effects. The fundamental IT-AFM stiffness values obtained were 
force-displacement slopes. A slope was defined as the mean ratio of cantilever deflection (an 
expression of force) to piezoelectric displacement in the initial unloading part of the load-
displacement curve, as described in our previous work [24]. We set the maximum value for 
nanostiffness to one (corresponding to a slope of one) and displayed all other values at the 
nanoscale relative to one. The value for microstiffness obtained on articular cartilage (0.15 M 
NaCl) was set to 0.5. The bin width was set by dividing the maximum value = 1 × 50 (bars), 
yielding a dimensionless bin width of 0.02. Slope values alone are sufficient to determine and 
compare micro- and nanostiffness distributions of IT-AFM measurements. The slopes from a 
given square grid of IT-AFM measurements were then used to create a slope histogram. The 
subsequent calculation of microstiffness aggregate modulus (E
*
) values from the slope data 
was performed as previously described [24] (see also Appendix I). To calculate the 
nanostiffness aggregate modulus (E
*
 values), the functional relationship y(x) = (21/(1 − x)) − 
21 was derived from a calibration curve using agarose gels [24] (see also Appendix I). 
 
2.4 Results 
 
Articular cartilage exhibits a scale-dependent mechanical behavior: micro- versus 
nanostiffness 
As documented in Fig. 2.2 A, when articular cartilage is imaged with a ~10-μm-diameter 
spherical tip (see Fig. 2.1 A), the sample surface appears relatively uniform and flat. 
However, to demonstrate that recording the image and the force map of the same specimen 
area is meaningful, we show a location that exhibits some coarse surface irregularities. 
Although such a micrometer-size AFM tip cannot resolve the cartilage's fine structural 
elements, such as individual collagen fibrils, the force map displayed in Fig. 2 B, which is 
derived from 64 × 64 (i.e., 4096) IT-AFM curves, clearly correlates with the surface 
irregularities observed in the AFM height image shown in Fig. 2.2 A. Fig. 2.2 C reveals that 
the unloading slope histogram for the 4096 force curves in Fig. 2.2 B exhibits a narrow 
Gaussian distribution centered about a slope of 0.53. Fig. 2.2 D displays an averaged curve, 
giving a calculated microstiffness of Emicro = 1.3 ± 0.4 MPa. 
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Figure 2.2: Images and IT-AFM measurements of stiffness of articular cartilage and a PEGT/PBT-
fibril/agarose/chondroitin sulfate gel composite at the micro- and nanometer scales. Images and force maps 
on cartilage are scaled to a height of 400 nm, whereas images and force maps on the model material are scaled 
to a height of 2000 nm. All scale bars correspond to 2 μm. (A–D, first column) Micrometer-scale information for 
cartilage. (A and B) The corresponding nanometer scale data. (C) Distribution of raw stiffness values (scaled 
slopes) obtained from the IT-AFM force/displacement curves. (D) Distribution of force curves and the value of 
E
*
. (E–H, second column) Analogous information obtained at the nanometer scale. The third and fourth columns 
show analogous images and data for the model material. 
 
Fig. 2.2 E shows the AFM height image of the same articular cartilage surface, but now 
recorded by a sharp, nanometer-size tip (see Fig. 2.1 B). At this resolution, individual 
collagen fibrils appear as bright filamentous structures that are separated by nonstructured 
darker areas. The corresponding force map in Fig. 2.2 F, which represents a 12 μm × 12 μm 
specimen area, also shows the locations of the individual collagen fibrils on the articular 
cartilage surface. Therefore, any two adjacent points in this 64 × 64 pixel force map are 
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spaced 187.5 nm apart. As documented in Fig. 2.2 G, calculation of the slope for each pixel 
in this force map yielded a histogram with a bimodal distribution, with the two Gaussian fits 
being centered about slopes of 0.51 and 0.87, respectively. Accordingly, Fig. 2.2 H reveals 
the two averaged force-displacement curves computed from the 2% of curves centered about 
the peaks of the two Gaussian fits (corresponding to an average of a few hundred curves, 
depending on the width of the Gaussian fit). From these, nanostiffnesses of 22.3 ± 1.5 kPa 
and 384 ± 50 kPa, respectively, were calculated and found to be ~100× and ~6× less than the 
corresponding microstiffness of 1.3 MPa that was determined with a micrometer-size tip (see 
Fig. 2.2, C and D). 
 
Comparison of authentic articular cartilage with a model gel-microfiber composite 
Next, we wanted to test our hypothesis that the bimodal distribution shown in Fig. 2.2 G is 
caused by an interaction of the sharp, nanometer-size tip with the two different structural 
components comprising the cartilage (i.e., the collagen fibrils and the PG moiety). For this 
purpose, we prepared a PEGT/PBT-fibril/agarose/chondroitin sulfate gel composite material 
to mimic articular cartilage's relatively stiff collagen meshwork and the softer PG gel moiety. 
Probing the resulting model material by IT-AFM at the micro- and nanometer scale clearly 
confirmed that its composite structure consisted of stiff fibrils and a soft matrix similar to that 
of cartilage. 
Accordingly, Fig. 2.2 I displays an AFM image of the model material recorded by a 
micrometer-size spherical tip (see Fig. 2.1 A). Next, from the same specimen area and using 
the same spherical tip, 64 × 64 force-displacement curves were recorded. The resulting force 
map is shown in Fig. 2.2 J, and Fig. 2.2 K reveals the distribution of microstiffness slope 
values for the 4096 points from the force map in Fig. 2.2 J. Fig. 2.2 L displays the averaged 
force-displacement curve computed from the 2% of curves centered about the peak of the 
Gaussian fit (see Fig. 2.2 K), from which a microstiffness of 15.2 ± 0.5 kPa was calculated. 
Compared to cartilage (see Fig. 2.2 C), the Gaussian distribution is slightly wider and 
centered about a much lower slope value (0.15 vs. 0.54 for cartilage). The corresponding E
*
 
value calculated from the slope data (15.2 ± 0.5 kPa) shows that the microstiffness of the 
model material amounted to only 0.66% of the stiffness of cartilage (i.e., 1.3 MPa; see 
Fig. 2.2 D). 
In contrast to Fig. 2.2 I, which was recorded by a micrometer-size spherical tip, Fig. 2.2 M 
displays an AFM height image of the model material registered by a sharp, nanometer-size 
pyramidal tip (see Fig. 2.1 B). At this scale, the PEGT/PBT fibrils can clearly be resolved in 
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both the AFM height image (Fig. 2.2 M) and the corresponding force map recorded by IT-
AFM of the same specimen area (Fig. 2.2 N). Analogously to the case with cartilage (see 
Fig. 2.2 G), the slope histogram shown in Fig. 2.2 O exhibits a bimodal distribution, with the 
two Gaussian fits being centered about slopes of 0.18 and 0.89, respectively. Accordingly, 
Fig. 2.2 P reveals the two averaged force-displacement curves computed from the 2% of 
curves centered about the peaks of the two Gaussian fits. From these, the nanostiffnesses of 
5.1 ± 1.2 kPa and 251 ± 40 kPa, respectively, were calculated and found to be ~3× smaller 
and ~6× larger, respectively, than the corresponding microstiffness of 15.2 ± 0.5 kPa that was 
determined with a micrometer-size tip (see Fig. 2.2, K and L). Hence, in contrast to its 
microstiffness, the model material's nanostiffness is within the same order of magnitude as 
that of articular cartilage for both its hard (i.e., the PEGT/PBT-fibrils) and soft (i.e., the 
agarose/chondroitin sulfate gel) phases. 
 
Effects of ionic-strength changes on the micro- and nanostiffness of authentic articular 
cartilage and a model gel-microfiber composite—a comparison 
To ascertain the effect of osmotically induced changes in water content and the resultant 
water pressure within cartilage and the model material, we probed the micro- and 
nanostiffness of both articular cartilage and the model material in isotonic PBS buffer and 
hypertonic PBS. We performed measurements by exchanging the buffer in the fluid cell of 
the AFM without moving the positions of the tip and sample. We expected that, as a result of 
osmotic effects, an increase in salt concentration would decrease water content and increase 
the nanostiffness of the gel phase. Also, we wanted to determine how much a decrease in 
water content in the gel phase would affect the overall microstiffness. As shown in Fig. 2.3 A, 
the change to hypertonic PBS increased the slope of the cartilage microstiffness by 21% but 
did not affect its unimodal frequency distribution. Fig. 2.3 B shows the corresponding effects 
of the change from isotonic to hypertonic PBS on cartilage nanostiffness. The bimodal 
distribution of nanostiffness was maintained. However, the slope of the lower peak increased 
by 28%, whereas the increase in slope of the higher peak was insignificant. 
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Figure 2.3. Stiffness distributions of cartilage and the model material at the micro- and 
nanometer scales and at two different ionic strengths of the PBS bathing solution. Stiffness is 
expressed as the scaled slopes of the IT-AFM unloading curves (see text) 
 
Fig. 2.3, C and D, reveal the analogous results for the model material. As in cartilage, the 
microstiffness (Fig. 2.3 C) of the model material was also unimodal under both ionic 
strengths, but hypertonicity increased the stiffness slope by 31%. Again, as in cartilage, the 
nanostiffness (Fig. 2.3 D) was bimodal. Hypertonicity increased the stiffness (slope) of the 
lower peak by 34%, whereas the increase in slope of the higher peak was again negligible. In 
contrast, an agarose model material lacking the chondroitin sulfate moiety did not change the 
stiffness at either scale when exposed to hypertonic PBS (data not shown). 
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2.5 Discussion 
Micro- versus nanometer-scale dynamic stiffness measurements 
Fig. 2.1 shows what the indenter “sees” during imaging and what it “feels” in indentation 
testing when the articular cartilage surface is probed at the (A) micrometer or (B) nanometer 
scale. In particular, the micrometer-size tips assess the overall tissue resistance to 
deformation, where multiple structural elements of the tissue are deformed in concert. In 
contrast, a nanometer-sized tip can assess the stiffness of cartilage at the level of the fibrils 
alone and the gel alone. Stiffness changes potentially reveal structural changes, especially in 
the gel phase. This information is relevant because of the important role played by PGs (in 
particular the charged glycosaminoglycan chains) in normal cartilage function and the 
structural changes that occur in aging and osteoarthritis [12, 16, 25, 29, 30]. 
 
Source of unimodal microstiffness distributions in articular cartilage 
For both cartilage and the model material, indentation stiffness at the micrometer scale, as 
shown in Fig. 2.2, A–D, and I–L, reveals a uniform appearance in both images and force 
maps, and a homogeneous (unimodal) distribution of stiffness values. This homogeneity can 
be explained by the large size of the IT-AFM tip relative to the molecular-scale structures 
within the cartilage, i.e., the size of a 10-μm-diameter tip is three orders of magnitude larger 
than the nanometer-scale PG structures and two orders of magnitude larger than the collagen 
fibril meshwork of typically d = 50–150 nm in articular cartilage. 
 
Source of bimodal nanostiffness distributions in articular cartilage 
We hypothesized that the interaction between the nanoindenter and the PG gel in articular 
cartilage would produce a lower stiffness peak, and the interaction with the resilient collagen 
fibrils would produce a higher stiffness peak, as shown in Fig. 2.2 G. The results obtained at 
the nanometer-scale with the model material also showed a bimodal distribution of stiffness, 
as was observed in cartilage. In addition, exposing the model material to hypertonic saline 
instead of isotonic saline, as shown in Fig. 2.3, shifted the lower stiffness peaks upward while 
the upper stiffness peak remained unchanged. Since in both cartilage and the model material 
only the porous gel structure with a high density of negatively charged surface is influenced 
by changes in ionic strength, these results strongly support our hypothesis that the lower peak 
represents the stiffness of the PG gel, whereas the upper peak is a measure of the stiffness of 
the collagen fibrils. 
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Relative stiffness of cartilage and the model material 
The structural and physicochemical differences between cartilage and our model system 
explain the differences in stiffness at both the micro- and nanometer scales. 
1) The collagen fibrils of cartilage form a 3D collagen meshwork with extensive cross-
linking by covalent bonds, which provides superior resistance to deformation but also greatly 
inhibits the movement of the soft PG moiety during loading. Because of its low permeability, 
the cartilage initially tends to deform rather than decrease in volume, and consequently places 
the collagen meshwork under tension, resulting in a high initial overall stiffness. 
2) In contrast, in the model material, the PEGT/PBT fibrils are neither cross-linked nor 
spatially stabilized by any strong interactions, and therefore do not offer the same resistance 
to gel-induced deformation. 
 
Accuracy of calculated values of E
*
 for collagen and PEGT/PBT fibrils 
A spring constant of k = 0.06 N/m is optimal for probing the gel phase, but it does not allow 
one to quantitatively measure the stiffness of the collagen fibrils with the same accuracy. To 
compute values of nanostiffness from the slopes, we employed the calibration curve 
established by Stolz et al. [24]: y(x) = (21/(1 − x)) − 21. However, this calibration curve 
exhibits an asymptotic behavior that results in large errors for slopes close to one. Since it is 
difficult to reliably measure the nanostiffness of hard fibrils using a k = 0.06 N/m cantilever, 
we present the results with large standard deviations (see Appendix II). 
 
Effects of ionic strength on cartilage stiffness 
Our measured increase of microstiffness by osmotic loading is in general agreement with 
previous observations [10, 11, 13, 16, 31-35]. However, we measured a change of 
microstiffness of only ~21% in hypertonic PBS compared to published values of ~50% in 
hypertonic PBS and a 1 M NaCl bathing solution [13, 31, 35]. This apparent discrepancy may 
be explained by major differences between the experimental setups: Eisenberg and 
Grodzinsky [13] performed confined compression tests by employing a porous indenter 
(diameter d = 6.4 mm) that was capable of taking up and retaining significant amounts of 
water, whereas we performed indentation tests using a much smaller (d = 10 μm) spherical 
indenter. Furthermore, those authors applied much larger forces to the cartilage, which 
resulted in substantial indentation depths. Also, they trimmed off the surface and thus probed 
deeper zones, whereas we tested the intact surface by applying indentation depths on the 
order of only ~1 μm. Therefore, we tested the superficial zone, where PGs are less dense than 
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in the deeper zones [35, 36]. Moreover, protocols for compression testing of cartilage 
typically employ much lower loading rates or use a series of short discrete compressive 
strains to measure the equilibrium stiffness. We measured the dynamic aggregate modulus E
*
 
at a rate of three indentations per second. Cartilage stiffness is strongly affected by the 
deformation rate, and therefore the higher stiffness measured in this study may be at least 
partly the result of the higher rates employed. 
 
Relation of IT-AFM cartilage nanostiffness values to reported values for isolated 
cartilage structures 
In previous studies, single collagen fibrils exhibited stiffness in tension and indentation of a 
few gigapascals [37, 38]. However, it is difficult to directly compare those results with the 
IT-AFM-measured nanostiffness of collagen in native cartilage. The IT-AFM values reported 
here are much lower (e.g., 384 kPa). They are in effect a measure of the dynamic bending 
stiffness of a collagen fibril that is part of a cross-linked meshwork and embedded in the PG 
moiety. In contrast, the mechanical behavior of isolated aggrecan gels at physiologically 
relevant concentrations of 20–80 mg/mL [31, 34] exhibited stiffness of only ~1 kPa [39, 40]. 
However, measurements of the isolated components do not take into account their behavior 
within the tissue. In particular, PGs in articular cartilage are cross-linked. Therefore, our 
higher values of EPg = 22.3 ± 1.5 kPa for the cartilage gel phase measured in situ reflect the 
intact cross-links in PG. These results are even more plausible when we consider the 
contribution made by the dynamically cross-linked meshwork of collagen fibrils to the PG 
nanostiffness. 
 
Value of nanometer-scale dynamic stiffness measurements 
Nanomechanical structures govern the functional behavior and success or failure of 
engineered cartilage. Our composite model provides a material that can be tuned by adjusting 
the total PEGT/PBT content, fibril length, fibril diameter distribution, and fibril orientation, 
and by creating an interfibrillar meshwork by introducing covalent cross-links. In addition, 
the density and other parameters of the agarose/chondroitin sulfate moiety can be modified 
by varying the charged groups or the concentration of agarose, or including a low 
concentration of polyacrylamide. Such a tunable artificial tissue could be valuable for 
interpreting and even predicting structure-mechanical property relationships on different 
length scales, and the resultant data could be used to further improve engineered cartilage. 
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2.6 Conclusions 
A primary challenge in evidence-based medicine is the need for early detection of various 
diseases, such as osteoarthritis [25], artherosclerosis [41], and cancer [42], ideally at the 
presymptomatic stage. AFM-based indentation testing has yielded some encouraging results 
in terms of detecting systematic changes in the nanostiffness of articular cartilage during the 
progression of osteoarthritis [43]. Monitoring scale-dependent changes in tissue plasticity 
during disease progression or in response to different treatment modalities may lead to the 
development of novel diagnostic tools [44] and therapeutic interventions. Nevertheless, there 
still remain a number of technical difficulties involving data collection and analysis that must 
be overcome before AFM-based indentation testing can be moved from the bench to the 
patient [42]. In this study, we have attempted to explain the observed scale-dependent 
stiffness of articular cartilage when measured by IT-AFM, and to rationalize this finding in 
terms of cartilage biology and pathology [25]. It is hoped that the insights gained will be 
more generally applicable to scale-dependent analyses, and enhance our understanding of 
tissue mechanics. 
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2.8 Appendix I: Deformation Rate-Dependent Mechanical Response of Articular 
Cartilage 
The functional stiffness of articular cartilage is |E
*
|, the dynamic elastic modulus, as 
explained in Fig. 2.4. |E
*
| is a function of the rate of deformation and can be determined from 
cyclic load/displacement data. The rate employed should reflect the transient loading-
unloading time of normal ambulation (i.e., walking or running). In humans, this is in the 
range of a few hundred milliseconds [45]. Therefore, we performed indentation 
measurements at a rate of three complete loading/unloading cycles per second, corresponding 
to a tip unloading time of ~150 ms. Even after hundreds of loading/unloading cycles, we did 
not observe any progressive change in the load/displacement behavior, persistent residual 
indentations (which would be indicative of yield and plastic flow), or effects indicative of 
material fatigue. 
 
 
 
Figure 2.4: Illustration of stiffness parameter relationships for a viscoelastic material subjected to a cyclic 
dynamic force or deformation. At low frequencies, the magnitudes of force and deformation are out of phase, 
i.e., they do not reach maximum values simultaneously. This is expressed as the phase angle, φ, between their 
maximum values. As frequency is increased, φ decreases. In the limit φ = 0 and E* = E′, i.e., the material 
behaves as an elastic solid. The out-of-phase behavior is due to the inability of the viscous portions of the 
material structure to store energy. Thus φ is a measure of energy loss and is also called the loss angle or loss 
tangent.  
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2.9 Appendix II: Calculation of Stiffness Values from Indentation Curves 
Indentation tests were originally developed in the field of materials science [46] and more 
recently have been applied to study soft biological tissues at different scales of architectural 
organization [24, 25]. Mechanical properties, such as the dynamic elastic modulus, E
*
 (or 
stiffness, to use the more general term), can be obtained from unloading load-displacement 
curves as shown in Fig. 2.5 A. E
*
 (= E) was calculated from the following equation: 
 
 
A
S
E 21
2


  
ν = Poisson's ratio, S [N/m] = contact stiffness (slope of the initial part of the unloading 
regime of the load-indentation curve);  
dh
dP
S   
P [N] = applied force onto the indenter, h [m] = indentation; A [m
2
] = is the projected area of 
the spherical indenter at depth of indentation; 
2 A  
ρ = radius of the indenter as measured perpendicular to the tip axis at the depth of contact;  
 cc hrh  2  
r = radius of indenter; hc is depth of contact. To simplify the analysis, hc = h was assumed, 
where h is the total depth of indentation. 
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Figure 2.5. Graphs illustrating data and calculation of the dynamic elastic modulus (E*) at the (A) 
microscale (microstiffness) and (B) nanoscale (nanostiffness) from IT-AFM data. A shows a force-
displacement curve measured with a spherical indenter on articular cartilage. In addition, the curve of constant 
compliance (1 (nm/nm)) has been drawn in, and exhibits the force related to deflection of the AFM cantilever 
when in contact with a hard surface that allows no indentation to take place. B shows data and calculations of 
the dynamic elastic nanoscale modulus (nanostiffness) exemplified on three agarose gels exhibiting strengths of 
0.5%, 2.25%, and 3.5%. The graph displays the corresponding averaged force-displacement curves.  
 
Chapter 2: Stiffness measurements of native articular cartilage across scales 
 
49 
 
For the pyramidal tips as shown in Fig. 2.5 B, E is calculated as follows: 

E 
1 2 S
2h  tan
 
where θ is the half-opening angle of the tip (Fig. 5, inset). 
The indentation equations are based on Hertz's law, which is only true for linear elastic 
materials. The rationale for using them in this application is that the measured displacements 
are small and the displacement rate is high. Further, a Poisson's ratio of 0.5 was assumed, i.e., 
it was assumed that volume was conserved during deformation. Reported values of Poisson's 
ratio for cartilage range from 0.0 to 0.4, and also likely depend on deformation rates (see 
Table 3 in Mankin et al. [47]. Consequently, the values of E
*
 reported here are approximate 
and to some extent peculiar to the experimental methods and calculation assumptions 
employed. 
2.10 Appendix III: Accuracy of Measuring Stiffness 
If the cantilever is much stiffer than the stiffness of the material being indented, it will not 
deflect much and is thus an insensitive means of measuring force. If it exhibits a too-low 
spring constant, then too little indentation will occur at a given force. In particular, in IT-
AFM on cartilage with a nanometer-size indenter tip, the probe will interact with both the gel 
phase and the much stiffer collagen fibrils. Therefore, both a well-matched, low-stiffness 
cantilever (for testing the gel phase) and a higher-stiffness cantilever (for testing the collagen 
fibrils) are required to prevent errors due to mismatch of the spring constant in stiffness 
measurements. Unfortunately, the stiffness of the cantilever cannot be adjusted during the 
measurement and has to be selected in advance. In our work, the selected spring constant 
value, k = 0.06 N/m, was suitable for accurately testing the gel phase; however, it reduced the 
accuracy of measurements of the collagen fibrils, as expressed as large standard deviations in 
the calculated stiffness values. Similarly, the spring constant value, k = 0.06 N/m, was 
suitable for accurately testing soft gels (~0.5% agarose), as shown in Appendix II (Fig. 5, B), 
but it gradually overestimated the calculated values of nanostiffness for higher gel strengths. 
The IT-AFM measurement is most sensitive when the cantilever spring constant, k, and the 
contact stiffness, S = dP/dh ~ 2rE/(1 − ν2), are of similar magnitude. 
A calibration curve (sometimes also called blind calibration) was established in a previous 
study [24] to improve the quantitative capabilities of this method. The main advantage of this 
approach is that actual knowledge of the tip shape is not required. 
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3.1 Abstract 
 
Objective: Functional cartilage tissue engineering aims to generate grafts with a 
functional surface, similar to that of authentic cartilage. Bioreactors that stimulate cell-
scaffold constructs by simulating natural joint movements hold great potential to generate 
cartilage with adequate surface properties. In this study two methods based on atomic 
force microscopy (AFM) were applied to obtain information about the quality of 
engineered graft surfaces. For better understanding of the molecule–function 
relationships, AFM was complemented with immunohistochemistry. 
Methods: Bovine chondrocytes were seeded into polyurethane scaffolds and subjected to 
dynamic compression, applied by a ceramic ball, for 1 h daily [loading group 1 (LG1)]. In 
loading group 2 (LG2), the ball additionally oscillated over the scaffold, generating 
sliding surface motion. After 3 weeks, the surfaces of the engineered constructs were 
analyzed by friction force and indentation-type AFM (IT-AFM). Results were 
complemented and compared to immunohistochemical analyses. 
Results: The loading type significantly influenced the mechanical and histological 
outcomes. Constructs of LG2 exhibited lowest friction coefficient and highest micro- and 
nanostiffness. Collagen type II and aggrecan staining were readily observed in all 
constructs and appeared to reach deeper areas in loaded (LG1, LG2) compared to 
unloaded scaffolds. Lubricin was specifically detected at the top surface of LG2. 
Conclusion: This study proposes a quantitative AFM-based functional analysis at the 
micrometer- and nanometer scale to evaluate the quality of cartilage surfaces. Mechanical 
testing (load-bearing) combined with friction analysis (gliding) can provide important 
information. Notably, sliding-type biomechanical stimuli may favor (re-)generation and 
maintenance of functional articular surfaces and support the development of mechanically 
competent engineered cartilage. 
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3.2 Introduction 
Articular cartilage is a smooth, wear-resistant tissue that adsorbs impact forces and allows 
for almost frictionless gliding of the two opposing surfaces within a joint. The articular 
surface has a unique function in cartilage homeostasis and nutrition, but also in filtering 
large proinflammatory macromolecules present in the synovial fluid, thus protecting the 
cartilage from immune reactions [1]. It is characterized by high level of collagen fibrils 
oriented parallel to the joint surface, lower levels of proteoglycans in comparison to the 
underlying zones of cartilage, and a high concentration of densely packed lubricin 
molecules [1] and [2]. Lubricin, also known as cartilage superficial zone protein or 
proteoglycan-4, is a large, water-soluble and flexible rod-shaped glycoprotein present in 
both the synovial fluid and on the cartilage surface [3], [4] and [5]. Several studies have 
shown that lubricin plays a key role in the protection of the surface from friction and wear 
in articulating joints [4], [6] and [7]. Hence, the intact cartilage surface has a vital role in 
providing a highly efficient lubrication mechanism with a low coefficient of friction that 
is mediated by boundary lubricants such as lubricin and hyaluronan [8]. The direct 
contact of the superficial zone with the synovial fluid is considered to be important for 
cartilage function and maintenance [8]. Deterioration of the superficial zone considerably 
alters cartilage homeostasis and mechanical properties, which often result in the 
development of osteoarthritis (OA) [9] and [10]. Moreover, the cartilaginous matrix is 
generated by a low density of chondrocytes, which together with their low metabolic 
activity and the avascular nature of the cartilaginous tissue results in a limited repair 
capacity of damaged cartilage [2] and [11]. 
Articular cartilage injuries and degenerative joint diseases affect a considerable 
proportion of the population. While cartilage injuries are occurring in all age groups, it is 
estimated that 68% of individuals older than 55 years have radiographic evidence of OA 
[12]. Established surgical treatment strategies range from debridement, marrow 
stimulation techniques, a variety of cell and tissue transplantation techniques, to total joint 
replacement1 [3]. In particular, autologous chondrocyte transplantation (ACT) and matrix 
induced chondrocyte implantation (MACI) have been frequently applied in orthopedic 
practice, but there is still a considerable failure rate [14]. An appropriately developed 
tissue engineered construct may have better chances to withstand the forces that impact 
the cartilage during daily activities compared to techniques where chondrocytes are 
directly administered into the cartilage defect. Surface properties of engineered cartilage 
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that are similar to native cartilage are likely to be beneficial for tissue homeostasis and 
mechanical function required for a high success rate. 
Engineering of cartilaginous tissue implies culturing of either chondrocytes or 
mesenchymal stem cells within a three-dimensional natural or synthetic biomaterial [15]. 
Biomechanical cues are increasingly employed to stimulate the development of functional 
articular cartilage. A variety of different bioreactors and loading devices have been 
designed that typically apply dynamic compressive load, shear strain, fluid flow, 
hydrostatic pressure, or a combination of these stimuli [16]. Our custom designed 
bioreactor system is based on the implementation of motion patterns which approximate 
the kinematics of physiological joint motion to support the generation of a tissue with 
properties similar to native articular cartilage [17]. Studies have shown that dynamic 
compression and sliding surface motion, applied by a ceramic ball, improves the gene 
expression and the synthesis of cartilage specific matrix molecules in chondrocytes-
scaffold constructs [18], [19] and [20]. 
Quality control, i.e., measuring the mechanical properties of the tissue engineered 
cartilage and in particular of the surface zone is crucial for generating tissue engineered 
cartilage constructs that can be used to repair damaged sites in the joints. Notably, the 
Food and Drug Administration (FDA) recently requested mechanical data for all articular 
cartilage repair products in their guidance for “Repair or Replace Knee Cartilage” 
(ucm072952) [21], which additionally emphasizes the importance of mechanical 
characterization of cartilage constructs. Recently, atomic force microscopy (AFM) has 
been proposed to assess cartilage integrity at the micro- and nanometer scale [22], [23] 
and [24]. Owing to its high scale sensitivity AFM has the potential to not only detect 
early degenerative changes of the articular surface but also to determine the functional 
characteristics of an immature and still developing tissue. 
Here, we characterized the functional surface properties of tissue engineered cartilage by 
friction force and indentation-type AFM (IT-AFM). Cell-scaffold constructs that were 
cultured free swelling were compared with constructs stimulated by dynamic axial 
compressive loading with or without superimposed sliding surface motion. We 
hypothesized that the mechanical loading regime which includes sliding motion and 
hence simulates natural joint movements would generate constructs with surface 
properties closer to authentic articular cartilage. 
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3.3 Materials and Methods 
Polyurethane scaffold 
Polyurethane scaffolds (8 mm diameter; 4 mm height) with interconnected pores had an 
average pore size of 90–300 μm and a pore-to-volume ratio of 85% [25]. The polymers 
were synthesized with hexamethylene diisocyanate, poly(ɛ-caprolactone) diol with a 
molecular mass of 530 Da, and isosorbide diol (1,4:3,6-dianhydro-d-sorbitol) as chain 
extender [25]. Scaffolds were sterilized in a cold-cycle (37°C) ethylene oxide process and 
subsequently evacuated at 45°C and 150 mbar for 3–4 days. Before cell seeding, the 
scaffolds were evacuated in the presence of growth medium for 1 h, in order to wet the 
hydrophobic polymer. 
Chondrocyte isolation, seeding and culture conditions 
Chondrocytes were isolated from full thickness metacarpal joint cartilage of 4–8 months 
old calves using sequential pronase and collagenase digestion [26]. Isolated chondrocytes 
(5 × 106/scaffold) were suspended in 75 μL fibrinogen solution. Then an equal volume of 
thrombin solution was added, the suspension was mixed and infiltrated into the pores of 
the scaffold. This was achieved by pressing the elastic and resilient scaffold into the cell 
suspension and slowly releasing it, causing the cells to be imbibed. With this method a 
uniform cell distribution throughout the scaffold is obtained [27]. The fibrin components 
were provided by Baxter Biosurgery (Vienna, Austria). The final concentrations of the 
fibrin gel were 17 mg/mL fibrinogen, 0.5 U/mL thrombin, and 665 KIU/mL aprotinin. 
Constructs were incubated for 1 h (37°C, 5% CO2, 95% humidity) to permit fibrin 
gelation before adding growth medium (Dulbecco’s Modified Eagle’s medium (DMEM) 
supplemented with antibiotics, 10% fetal calf serum (FCS), 50 μg/mL ascorbic acid, 40 
μg/mL l-proline, non-essential amino acids, and 500 KIU/mL aprotinin). Cell-scaffold 
constructs were placed into the sample holders (Fig. 1), and 3 mL of growth medium 
were added. Medium was changed every second day, and conditioned medium was 
collected for analysis of sulfated glycosaminoglycan (sGAG). After 6 days in free 
swelling culture, the samples were exposed to mechanical loading regimes as described 
below. 
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Figure 3.1: Bioreactor used for mechanical conditioning of cell-scaffold constructs. A ceramic ball was 
pressed onto the cell-seeded scaffold. In scaffolds of LG1 and LG2, the ball oscillated at 1 Hz between 10% and 
20% of the scaffold height (in the center of the construct). In scaffolds of LG2, the ball additionally oscillated 
about an axis perpendicular to the scaffold axis at amplitude of ±25° and 1 Hz. 
 
Mechanical loading 
Mechanical conditioning of cell-scaffold constructs was performed using our four-station 
bioreactor system, which was installed in a CO2 incubator at 37°C, 5% CO2, 85% 
humidity (Fig. 1) [17]. At each station a commercially available ceramic hip ball (32 mm 
in diameter) was pressed onto a cell-seeded scaffold to provide a constant displacement of 
0.6 mm or 15% of the scaffold height (measured in the construct center). In scaffolds of 
loading groups 1 and 2 (LG1 and LG2) the ball oscillated in a sinusoidal manner between 
0.4 mm and 0.8 mm, i.e., between 10% and 20%, of the scaffold height at a frequency of 
1 Hz. In scaffolds of LG2, interface motion was generated in addition to the cyclic 
compressive loading by reciprocating rotation of the ball about an axis perpendicular to 
the scaffold axis at amplitude of ±25° and 1 Hz. This regime of dynamic axial 
compression with superimposed sliding motion is suggested to more closely simulate 
joint articulation compared to axial compression alone [17]. 
One hour of mechanical loading was performed daily for 6 days/week. In-between 
loading cycles constructs were kept in a free swelling condition (without ball contact). 
Construct analysis was performed after a total culture time of 4 weeks including 3 weeks 
of mechanical loading. Unloaded scaffolds served as controls. 
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Sample preparation for friction and stiffness measurement by AFM 
The cylindrical cell-scaffold constructs were cut vertically into four equal sections. Each 
quadrant was glued onto a round Teflon disk with the 5 min Epoxy glue (Devcon, 
Danvers, Mass., USA). An additional supporting plastic ring around the sample was used 
in order to ensure full immersion of the sample in phosphate buffered saline (PBS) 
containing protease inhibitor cocktail (Complete, Boehringer Mannheim). Half of the 
sample (two quadrants) was used for indentation testing, while the other half was used for 
friction testing. Articular cartilage was harvested from 4 to 8 months old calves and also 
tested for indentation and friction as described below. 
Indentation testing 
Indentation testing was performed using the Nanoscope IIIa AFM (Veeco, Santa Barbara, 
USA) as described previously [23]. Briefly, stiffness values were measured at the 
micrometer- and nanometer scale. Micrometer scale measurements were performed using 
borosilicate glass spheres (r = 5 ± 1 μm, Duke Scientific Corporation, Palo Alto, USA) 
that were glued onto tip-less cantilevers, lengths l = 350 μm, spring constants of k = 0.3 ± 
0.1 N/m (NSC12, MikroMasch, Tallinn, Estonia). For nanometer-scale stiffness 
measurement, silicon nitride pyramidal tips (height = 20 ± 4 μm, cantilever k = 0.08 ± 
0.02 N/m, CSC38/Si3N4/AlBS, MikroMasch, Tallinn, Estonia) were used. Prior to the 
experiment, the deflection sensitivity and the spring constant were measured for each 
cantilever. The normal spring constant was experimentally determined by the Sader 
calibration method [28]. Stiffness was calculated from load-displacement curves recorded 
on at least eight random locations of the sample surface at two different maximum 
applied forces, i.e., 2.4 nN (nanometer scale) and 12.5 nN (micrometer scale). Indentation 
testing was performed at 3 Hz. Stiffness was calculated from the measured raw AFM 
curves. For the automated analysis of AFM data custom made LABVIEW software 
(National Instruments, USA) was used. The contact point was determined by applying a 
polynomial fit to raw force curves according to a published algorithm [29] and [30]. The 
slope of each data point is calculated by performing a linear fit to the upper 50% of the 
unloading force curve. Stiffness (elastic modulus) was calculated accordingly as 
described by Oliver and Pharr [31]. 
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Friction testing 
Friction measurements were performed using the Nanowizard I BioAFM (JPK, Berlin, 
Germany). Tip-less cantilevers (vertical k = 0.2 ± 0.05 N/m) with attached microsphere 
probes were used. Borosilicate microsphere probes (5 ± 1 μm, Duke Scientific 
Corporation, Palo Alto, USA) were coated with tetra-ethylene glycol to reduce unspecific 
adhesion between the probe and sample surface [32] and [33]. Friction was measured by 
recording the lateral deflection signal as the probe scanned over the samples at a velocity 
of 40 μm/s and scan angle of 90°. The friction force was calculated by multiplying the 
half-width of the friction loop (one-half of the voltage difference between mean lateral 
trace and mean lateral retrace) by the torsional calibration factor (nN/V). The torsional 
calibration factor was determined by lateral manipulation of small glass fibers as 
described previously [33]. Friction forces were measured on at least three different sites 
of the samples and with five different vertical loading forces (10 nN, 20 nN, 30 nN, 40 
nN, 50 nN) applied. Finally, the friction forces were plotted as a function of the vertical 
loading force, with the resulting slope defining the coefficient of friction. 
Biochemical analysis 
Scaffolds were digested overnight using 0.5 mg/mL proteinase K at 56°C. The DNA 
content was measured spectrofluorometrically using Hoechst 33258 dye (Polysciences 
Inc., Warrington, PA, USA) and purified calf thymus DNA as a standard. The amount of 
sGAG was determined by the dimethylmethylene blue dye method, using bovine 
chondroitin sulfate as a standard. Total sGAG content of the culture media was also 
measured to assess the release of matrix molecules from the constructs into the media. 
Immunohistochemistry 
For immunohistochemical analysis scaffolds were fixed in methanol at 4°C and incubated 
in 5% d(+)sucrose solution in PBS for 12 h at 4°C before cryo-sectioning at 12 μm. After 
enzyme pretreatment (0.25 U/mL Chondroitinase AC for aggrecan and 0.5 U/mL 
Hyaluronidase for collagen types I and II staining), sections were blocked with 5% horse 
serum. Then the sections were incubated using primary antibodies against collagen type I 
(Sigma–Aldrich, Inc., Saint Louis, Missouri, USA; 1:2000 dilution), collagen type II 
(CIICI supernatant; Development Studies Hybridoma Bank (DSHB), University of Iowa, 
Iowa City; IA, USA; 1:6 dilution), aggrecan (12/21/1-C-6; DSHB; 1:10 dilution) [34] and 
[35], and lubricin (3A4; 1:400 dilution; kindly provided by Bruce Caterson, Cardiff 
University, UK). Before detection of aggrecan, a neo-epitope had to be generated by 
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reduction and alkylation steps [36]. Primary antibody was applied over night at 4°C, 
followed by biotinylated secondary antibody (30 min, RT) and the preformed avidin–
biotin–peroxidase complex [30 min, room temperature (RT)]. All detection reagents were 
taken from the Vectastain Elite ABC Kit (Vector Laboratories). As a chromogen 3, 3′-
diaminobenzidine monomer (DAB) was used. Sections from bovine articular cartilage 
that were prepared and probed according to the same protocol served as positive controls. 
For the negative controls, the primary antibody was replaced by PBS. 
Statistical analysis 
Values are reported as mean ± 95% confidence interval. Stiffness values (n = 5), 
coefficient of friction (n = 4), and sGAG content (n = 8) were evaluated by analysis of 
variance (ANOVA) and least significant difference (LSD) post hoc testing using SPSS 
v.16.0 to reveal differences between loaded and control scaffolds and between loading 
groups. P < 0.05 was considered as significant. 
 
3.4 Results 
Indentation Testing 
Both micrometer scale and nanometer-scale stiffness were different between the groups. 
Lowest stiffness values were measured for the unloaded control group. For constructs from 
LG1, the average nanostiffness was 15.9 ± 6.4 kPa (P = 0.053 vs control), while 
microstiffness values of 23.9 ± 9.2 kPa were recorded (P = 0.055 vs control). Constructs of 
LG2 demonstrated highest stiffness values at both the nanometer scale (33.3 ± 6.5 kPa) and 
micrometer scale (46.6 ± 10.2 kPa) levels. Stiffness measurements from LG2 were 
significantly enhanced compared to both unloaded controls and scaffolds of LG1 (Fig. 2). For 
bovine cartilage nanostiffness values of 45.7 ± 13.6 kPa were measured, while microstiffness 
is in the range of 0.8 MPa (data not shown). 
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Figure 3.2: Stiffness of cell-scaffold constructs measured by nanoscale and mircoscale indentation type 
atomic force microscopy. Constructs of LG1 were stimulated by dynamic compression only; constructs of LG2 
were stimulated by dynamic compression and sliding surface motion; controls were not loaded. Nanostiffness 
was significantly higher in LG2 vs control (P < 0.001) and in LG2 vs LG1 (P = 0.003); microstiffness was 
significantly higher in LG2 vs control (P < 0.001) and in LG2 vs LG1 (P = 0.007). * = significant difference vs 
control; # = significant difference vs LG1 (mean ± 95% confidence interval; n = 5). 
 
Friction Coefficient  
A coefficient of friction of 0.681 ± 0.172 was measured for unloaded control scaffolds. 
Compared to the unloaded controls, the coefficient of friction was reduced in cell-scaffold 
constructs stimulated by axial compression alone (LG1) (0.427 ± 0.326). The surface of 
constructs exposed to cyclic axial compression combined with sliding surface motion (LG2) 
demonstrated a significantly decreased coefficient of friction compared to controls (0.251 ± 
0.183, P = 0.033) (Fig. 3). For bovine cartilage a friction coefficient of 0.121 ± 0.005 was 
obtained. 
 
Figure 3.3: Coefficient of friction of the surface of cell-scaffold constructs measured by atomic force 
microscopy. Constructs of LG1 were stimulated by dynamic compression only; constructs of LG2 were 
stimulated by dynamic compression and sliding surface motion; controls were not loaded. * = significant 
difference vs control (P = 0.033) (mean ± 95% confidence interval; n = 4). 
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Biochemical Analysis 
There was no difference in DNA content between the scaffolds of LG1 (35.9 ± 7.7 μg), LG2 
(36.5 ± 5.3 μg), and the unloaded controls (34.7 ± 9.5 μg), indicating that mechanical loading 
had no effect on cell proliferation. Amounts of sGAG retained within the constructs were 
slightly but not significantly higher in loaded (LG1: 821 ± 181 μg; LG2: 805 ± 163 μg) than 
in control scaffolds (658 ± 218 μg). However, total amounts of sGAG synthesized by the 
cells, i.e., sGAG accumulated within scaffolds and released into the medium, were 
significantly increased in loaded scaffolds (LG1: 2.90 ± 0.29 mg, P = 0.010; LG2: 2.96 ± 
0.32 mg, P = 0.006) compared to unloaded controls (2.23 ± 0.37 mg) (Fig. 4). 
 
 
Figure 3.4: Total amounts of sulfated glycosaminoglycans (sGAG) retained within cell-scaffold constructs 
and released into the culture medium. Constructs of LG1 were stimulated by dynamic compression only; 
constructs of LG2 were stimulated by dynamic compression and sliding surface motion; controls were not 
loaded. Total amounts of sGAG were significantly higher in LG1 vs control (P = 0.010) and in LG2 vs control 
(P = 0.006). * = significant difference vs control (mean ± 95% confidence interval; n = 8). 
 
Immunohistochemistry 
While the cell distribution is generally homogeneous after cell seeding, enhanced cell and 
matrix accumulation at the surface and the edges of the constructs can be noted after longer 
time in culture. This has often been observed in cell-seeded scaffolds and may be due to 
increased availability of nutrients at the periphery compared to the center of the constructs 
[27]. Histochemistry images of tissue engineered constructs and of bovine cartilage are 
shown in Fig. 5. Pronounced type II collagen staining was observed in both loaded and 
unloaded constructs over a depth of around 0.3–0.4 mm, while the staining intensity appeared 
less toward the central areas of the constructs [Fig. 5(a–c)]. In constructs of LG2, the staining 
appeared more uniform than in constructs of LG1 and in unloaded controls. Collagen type I 
staining was visible as a thin layer at the surface of loaded constructs, especially from LG2, 
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which appears similar to the collagen type I distribution in normal articular cartilage [Fig. 
5(g, h)]. In non-loaded controls and constructs of LG1, type I collagen staining appeared to 
reach deeper areas of the scaffolds [Fig. 5(e)]. Aggrecan staining was readily observed in all 
constructs and appeared to reach deeper areas in loaded (LG1, LG2) compared to unloaded 
scaffolds, while there was no difference in overall staining intensity [Fig. 5(i–k)].  
 
 
Figure 3.5: Immunolabeling of cell-scaffold constructs for collagen type II, collagen type I, aggrecan, and 
lubricin. Constructs of LG1 were stimulated by dynamic compression only; constructs of LG2 were stimulated 
by dynamic compression and sliding surface motion. Immunolabeling characteristics of bovine articular 
cartilage used as positive control are also shown. Scale bar = 100 μm. 
 
Similar to the appearance of the native articular surface, strong immunoreactivity for lubricin 
was noticed at the top surface of constructs from LG2. Some positive cells were also visible 
in deeper zones. In constructs of LG1 and in unloaded controls, the cells at the surface were 
mostly immunonegative for lubricin. However, interestingly, cells in deeper zones of the LG1 
and control scaffolds showed more pronounced lubricin immunoreactivity as compared to 
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scaffolds from LG2 [Fig. 5(m–p)]. Negative controls did not show any staining throughout all 
the sections. 
 
3.5 Discussion 
While numerous studies have been performed to optimize the quality of tissue engineered 
cartilage, most conventional cartilage testing devices lack high sensitivity and therefore do 
not allow for a more distinct inspection of mechanical surface properties. In contrast, AFM 
has recently been employed to evaluate cartilage ex vivo and in situ at greater detail [22], 
[23], [37], [38] and [39]. As one specific application, here we utilized a standard commercial 
AFM to demonstrate that dynamic compressive loading in combination with sliding surface 
motion, mimicking joint articulation, can considerably affect the surface characteristics of in 
vitro engineered cartilage in terms of (1) micro- and nanometer-scale stiffness, (2) friction 
coefficient and (3) histological manifestation. 
For constructs that were mechanically stimulated to resemble the natural motion 
characteristics (LG2), we obtained nanostiffness values similar to the ones measured for 
native cartilage [22]. Results from a recent study indicate that the nanostiffness values in the 
range of about 20 kPa reflect the stiffness of the proteoglycan gel present at the articular 
surface [37]. Thus, the increased nanostiffness in constructs subjected to compressive loading 
that was further enhanced by additional sliding motion may be attributed to increased 
proteoglycan content and/or increased cross-linking between the proteoglycan molecules and 
collagen molecules at the construct surface [9] and [37]. In native cartilage, both enzymatic 
digestion of cartilage proteoglycans and hyperosmotic challenge resulted in significant 
stiffening at the nanometer scale as a result of the loss in water content [22] and [37]. While 
monitoring of nanostiffness values has been proposed as a sensitive tool for detection of early 
degenerative damage of the cartilage surface [23], this study additionally shows the great 
potential of nanometer-scale indentation-type AFM (IT-AFM) to determine the functional 
properties of in vitro engineered cartilage surface already at the very early stages of graft 
development. 
Microstiffness data, although highest in constructs experiencing simulated-physiological 
loading, were still two orders of magnitude lower compared to values of native articular 
cartilage. This result is in agreement with other studies demonstrating that stiffness values of 
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natural cartilage are generally not reached after short to medium-term in vitro culture of 
engineered cartilaginous tissues [26], [40], [41], [42] and [43]. It is apparent that the elastic 
response of an immature in vitro developing tissue is significantly different from authentic 
mature cartilage; this is predominantly due to the early stage of collagen fibrillogenesis, 
where collagen microfibrils are very thin and without mature (pyridinoline, 
deoxypyridinoline) cross-link bonds [44] and [45]. Nevertheless, differences in microstiffness 
were noted between constructs cultured under different loading conditions. Several studies 
have reported that physical loading can improve the mechanical properties of tissue 
engineered cartilage [46] and [47], and recent findings have confirmed the benefit of sliding 
contact loading on the equilibrium modulus of chondrocytes-seeded agarose gels [48]. The 
superior microstiffness can result from an increased accumulation of extracellular matrix, 
particularly at the construct surface, in the loaded samples. Histochemical observations 
contribute to this hypothesis. In all constructs, type II collagen and aggrecan, the main 
macromolecules responsible for the strength and elasticity of the cartilage extracellular 
network, were abundant. In loaded constructs, the accumulation of matrix generally appeared 
to reach deeper areas, which may be related to improved transport of nutrients to the cells 
inside the scaffold. In contrast, in LG2 collagen type I was produced only in a thin layer at 
the surface, which has been shown also in natural articular cartilage. Although the presence 
of type I collagen at the articular surface has been described, its amounts and function remain 
a matter of debate and its effects on the surface properties will require further investigation 
[49], [50] and [51]. 
AFM has increasingly been employed to determine the frictional behavior of cartilaginous 
surfaces, as it appears particularly appropriate for friction measurements in boundary 
lubrication systems [32] and [52]. This study emphasizes the value of a sliding-type motion 
regime to effectively decrease the coefficient of friction at the construct surface, approaching 
the level of young bovine cartilage. It is suggested that the decrease in friction results from 
the specific accumulation of lubricin at the construct surface. This distinct layer of lubricin 
was noted only in the group subjected to sliding motion, adding to previous observations of 
enhanced gene expression and release of lubricin in cell-scaffold constructs upon application 
of surface motion [18], [19] and [20]. 
Lubricin has been proposed to serve as the primary lubricant in articular joints [52], [53], [54] 
and [55]. Relationship between the presence of lubricin and reduced friction in diarthrodial 
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joints has been widely documented [7] and [52]. Although in scaffolds that were stimulated 
by axial compression without surface motion no distinct layer of lubricin was noted at the 
surface, they showed lower coefficient of friction than the unloaded controls. This suggests 
that other features such as enhanced deposition of proteoglycans and altered orientation of 
collagen fibers in the superficial zone might also have contributed to a reduction in the 
friction coefficient [56] and [57]. The friction lowering effect of sliding contact motion has 
recently been shown also for chondrocytes-seeded agarose constructs [48]. Here we conclude 
that the molecular composition of the superficial zone is adapted by the local mechanical 
stimulus, decreasing friction, which is at least partly due to localized lubricin deposition. The 
contribution of the fibrin to the stiffness and friction was not assessed, which may be a 
limitation of this study. However, while fibrin may play a role at the beginning of culture, 
histological images after 4 weeks show that at least at the surface fibrin is largely replaced by 
extracellular matrix. Therefore it is suggested that the contribution of the fibrin to the 
stiffness and friction is minimal at this stage. 
The total amounts of sGAG produced by the chondrocytes during culture were enhanced in 
mechanically stimulated grafts, confirming previous reports of accelerated metabolic activity 
of chondrocytes exposed to mechanical cues. The retention rate of approximately 30% that 
was found in all constructs is comparable to previous findings with chondrocytes-seeded 
scaffolds [27]. Retention might depend on the presence of extracellular matrix before 
initiation of loading and on the capability of the scaffold to accumulate newly produced 
matrix molecules. Increased release of sGAG into the medium can be attributed to 
accelerated pressing out of unincorporated matrix molecules by the cyclic compression. 
Additional mechanisms may be related to an activation of matrix turnover including 
degrading enzymes or mechanical disruption as a result of the loading forces58. While 
aggrecan immunostaining appeared to reach deeper areas in loaded scaffolds, no apparent 
difference in overall staining intensity was noted. This is in agreement with the merely small 
differences in the amounts of sGAG measured in the differently cultured scaffolds. 
To conclude, while quantitative information on the matrix synthesis can be obtained through 
biochemical analysis and the type and distribution of matrix molecules can be evaluated 
through immunolabeling, additional measurements are needed to assess the functional quality 
of cartilaginous grafts. This study proposes a quantitative AFM-based functional analysis 
including friction testing (gliding) and multiscale mechanical testing (load-bearing). Such 
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quality tests are essential to provide reliable mechanical data for “articular cartilage repair 
products”, which is increasingly required by authorities for approval of new products and 
methods [21]. Moreover, this study emphasizes the functional characterization of superficial 
layer of cartilage due to its unique role in cartilage homeostasis and mechanical properties. 
Due to its high sensitivity and multifunctionality (imaging, stiffness and friction 
measurements) AFM can be useful to evaluate friction and stiffness behavior of the cartilage 
surface. Finally, our results underline the importance of a sliding-type biomechanical 
stimulus for the (re)generation and maintenance of an operative articular surface. This has 
implications for both in vitro tissue engineering as well as in vivo physical regenerative 
therapy regimes. 
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4.1 Abstract 
Bone marrow presents an attractive option for the treatment of articular cartilage defects as it 
is readily accessible, it contains mesenchymal progenitor cells that can undergo chondrogenic 
differentiation and, once coagulated, it provides a natural scaffold that contains the cells 
within the defect. This study was performed to test whether an abbreviated ex vivo protocol 
using vector-laden, coagulated bone marrow aspirates for gene delivery to cartilage defects 
may be feasible for clinical application. Ovine autologous bone marrow was transduced with 
adenoviral vectors containing cDNA for green fluorescent protein or transforming growth 
factor (TGF)-β1. The marrow was allowed to clot forming a gene plug and implanted into 
partial-thickness defects created on the medial condyle. At 6 months, the quality of articular 
cartilage repair was evaluated using histological, biochemical and biomechanical parameters. 
Assessment of repair showed that the groups treated with constructs transplantation contained 
more cartilage-like tissue than untreated controls. Improved cartilage repair was observed in 
groups treated with unmodified bone marrow plugs and Ad.TGF-β1-transduced plugs, but the 
repaired tissue from TGF-treated defects showed significantly higher amounts of collagen II 
(P<0.001). The results confirmed that the proposed method is fairly straightforward 
technique for application in clinical settings. Genetically modified bone marrow clots are 
sufficient to facilitate articular cartilage repair of partial-thickness defects in vivo. Further 
studies should focus on selection of transgene combinations that promote more natural 
healing. 
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4.2 Introduction 
Hyaline cartilage is a highly specialized tissue, with a unique three-dimensional structure that 
enables it to withhold tremendous mechanical forces inflicted during joint movement and a 
smooth surface allowing nearly frictionless contact between articulating joint surfaces. 
However, this tissue is also avascular, aneural and alymphatic with a low cell density 
embedded within the extracellular matrix (ECM). For these reasons, hyaline cartilage has 
very modest reparative and regenerative capabilities. Articular cartilage defects are very 
frequent, especially among active young adults and the working population. Such defects do 
not heal and, with time, often lead to premature osteoarthritis, consequently decreasing 
quality of life for the patient and adding substantially to health care costs. 
The restoration of damaged cartilage remains one of the biggest challenges in modern 
orthopaedics. There is no pharmacological treatment that promotes the repair of the cartilage. 
Current treatment modalities include microfracture, transplantation of ostechondral grafts and 
chondrocytes, use of biodegradable scaffolds or combination of these [1,2]. Although these 
procedures can produce initially good clinical results in terms of pain relief and improvement 
of joint function, they typically produce a fibrocartilagenouse repair tissue that is inferior to 
normal cartilage, such that long-term outcomes are less predictable and satisfactory[3]. 
New biological approaches to cartilage repair that are based on the use of cells and molecules 
that promote chondrogenesis or/and inhibit cartilage breakdown offer a promising alternative 
to current treatment options[4]. Any successful strategy that attempts to repair hyaline 
cartilage defects must include sufficient number of cells, appropriate signal to modulate 
cellular response and a scaffold that would contain the cells within the defect. Mesenchymal 
stromal cells (MSCs) present very attractive option for cell-based strategies as they can be 
readily isolated, expanded and, under appropriate conditions, differentiated into mesenchymal 
tissues such as cartilage, bone or muscle[5]. Numerous gene products such as transforming 
growth factor-β (TGF-β) [6], bone morphogenetic protein-7 (BMP-7) [7], insulin-like growth 
factor-1 (IGF-1) [8] and BMP-2 [9] have shown potential in regulating the process of growth, 
repair and regeneration of cartilage in animal models, but their use is limited by delivery 
problems and rapid clearance from the joint. This issue can be addressed by gene therapy 
approaches for delivering therapeutic gene products specifically to the site of repair[10,11]. 
In particular, viral vectors have been used successfully to modify graftable articular 
chondrocytes, periosteal cells and bone marrow-derived MSCs ex vivo, as well as for directly 
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modifying the synovial lining in vivo [12,13]. The use of scaffolds in cartilage repair is often 
required to contain, deliver and orient cells within their three-dimensional structure. Many 
different types have been tested in clinical and experimental settings, but the selection of 
suitable scaffolds for clinical application is still ongoing [14]. 
Much of the current research into cartilage repair has focused on ex vivo, or indirect, 
approaches to the treatment of defects using genetically modified cells. These typically 
involve harvesting and expansion of the cells, transduction with a therapeutic gene, seeding 
onto a scaffold and reimplantation into the defect. While providing the aforementioned 
components for successful cartilage repair, this general approach is technically demanding, 
expensive and requires at least two surgical procedures. Pascher et al. [15] have recently 
proposed an abbreviated ex vivo protocol that uses vector-laden, coagulated bone marrow 
aspirates or ‘gene plugs’, for gene delivery to cartilage defects. This study showed that 
nucleated cells within fresh autologous bone marrow aspirates may be successfully 
transduced with adenoviral vectors sufficient to secret transgene products up to 21 days. In 
theory, this approach also provides all necessary ingredients for successful cartilage repair: 
transduced mononuclear cells secrete signals that stimulate mesenchymal progenitors to 
differentiate along the chondrogenic lineage, and the bone marrow clot (BMC) itself provides 
a natural autologous three-dimensional scaffold to be used for containment of cells and 
vectors within the defect. 
To examine whether direct implantation of gene plugs might be used in situations that closely 
mimic real-life clinical situations, partial-thickness chondral defects were created on the 
weight-bearing surface of the femoral condyle in sheep. Fresh autologous bone marrow 
aspirates were transduced with adenoviral constructs carrying therapeutic or marker genes, 
and the clots were press-fit within the defects. The three principle objectives of this study 
were to determine feasibility of the proposed abbreviated ex vivo protocol to be used as a 
novel treatment tool in clinical settings, to determine whether transgene expression of TGF-
β1 within the gene plug enhances cartilage repair, and to test whether there is a presence of 
adenoviral genome within the cells of synovial lining, which would suggest vector leakage 
from the clots. 
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4.3 Results  
Histological assessment 
The mean scores of the histological assessment are shown in Table 4.1, and representative 
histological sections are shown in Figure 4.1. Six months after the surgical procedure, all 
groups treated with BMC transplantation were superior to empty control in terms of overall 
score according to the ICRS Visual Histological Assessment Scale, although statistical 
significance was not observed (P=0.061) (Table 4.1). Each histological parameter was 
analysed by Kruskal–Wallis test. A statistically significant difference was observed in one 
category—columnar cell distribution: TGF and BMC groups had a higher score than the 
CON group (Table 4.1). Although improved fusion between the repair tissue and the 
surrounding undamaged tissue had been achieved in TGF-treated groups, the side-to-side 
integrations were far from optimal. 
 
 
Figure 4.1: Representative histological sections of the repair tissue filling ovine chondral defects, stained 
with either haematoxylin-eosin (upper row) or safranin-O (lower row). Panel bars: 100 μm. (a, b) Empty 
defect group showing acellular tissue (Ac) within the defect with intact calcified layer (Ca) and subchondral 
bone (B). (c, d) BMC group. The defect is predominantly filled with fibrocartilage (Hf). There is clear 
demarcation between native hyaline cartilage (Hc) and fibrocartilage (Hf) separated by a defect gap (DG). Black 
arrow indicates border of the defect separating newly formed (New) and native (Nat) cartilage. Calcified layer 
(Ca). (e, f) GFP group. Irregular filling of the defect with fissures. The defect is filled with mixture of hyaline 
and fibrocartilage. Clusters of clonal cell division (Cl) are present in upper layers newly formed tissue. Black 
arrow indicates border of the defect separating newly formed (New) and native (Nat) cartilage. Calcified layer 
(Ca). (g, h) TGF group. Improved histological appearance of the repair tissue within the defect. Hyaline 
cartilage (Hc) and columnar organization of chondrocytes is detected on both sides of the defect gap (DG). 
Black arrow indicates border of the defect separating newly formed (New) and native (Nat) cartilage. Calcified 
layer (Ca). 
 
 
 
Chapter 4: AFM assessment of TEC after gene-therapy based treatment 
 
81 
 
Table 4.1: Histological grading of the repair tissue at 6 months according to ICRS visual histological 
assessment Scale
a
 (medians±interquartile range) 
ICRS Score  Treatment group  
  CON  BMC  GFP  TGF  Pb  
  C  Q  C  Q  C  Q  C  Q    
Surface 0.00 0 0.00 0 0.00 0 0.00 0 0.343 
Matrix 1.50 2 3.00 1 3.00 2 3.00 0 0.062 
Columnar cell distribution 1.00c  0 2.00 0 2.00 2 2.00 0 0.016 
Cell population viability 0.00 1 1.00 3 0.00 0 0.00 0 0.095 
Subchondral bone 2.50 1 3.00 0 3.00 3 3.00 0 0.177 
Cartilage mineralization 1.50 3 3.00 0 3.00 3 3.00 0 0.162 
Median total score 6.50 6 11.50 4 11.00 9 11.00 0 0.061 
 
Abbreviations: CON, control group; BMC, bone marrow clot group; GFP, green fluorescent protein group; 
TFG, transforming growth factor-β1 group, C, median; Q, interquartile range. 
a
 The table shows the medians from each group for each subcategories, and the total medians for each group. 
b
 Kruskal–Wallis test (Mann–Whitney test was used as a post hoc procedure when K–W test revealed 
statistically significant difference). 
c
 Significantly lower score from TGF and BMC groups (P=0.002 and P=0.008, respectively, Mann–Whitney 
test). 
 
In vitro culturing of genetically modified BMCs 
BMCs transduced with green fluorescent protein (Ad.GFP) showed a high number of 
fluorescent cells throughout the coagulate over 21 days of culture. BMCs formed in the 
absence of Ad.GFP confirmed the specificity of fluorescence signal. 
Biochemical properties 
Glycosaminoglycan (GAG) analysis did not reveal any statistical difference between mean 
values for repaired cartilage in the treatment groups and native cartilage from contralateral 
knees (P>0.050 for all comparisons, paired samples t-test; Figure 4.2a). There were no 
statistically significant differences in GAG mean values for repaired cartilage between the 
treatment groups (F2,19=0.6, P=0.581, one-way analysis of variance (ANOVA); Figure 4.2a). 
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Figure 4.2: Biochemical analysis of repaired cartilage compared with native cartilage. (a) GAG. (b) 
Collagen I. (c) Collagen II. (d) Water. 
*
Two-tailed paired t-test: comparison of repaired and native cartilage 
(P<0.05). 
†
One-way ANOVA with Tukey post hoc test: comparison of treatment groups (P<0.05). 
 
The collagen type I content was found to be significantly higher in all treatment groups when 
compared with native cartilage (P<0.050 for all comparisons, paired samples t-test; Figure 
4.1b). The three treatment groups also significantly differed in collagen type I content 
(F2,19=13.9, P<0.001, one-way ANOVA; Figure 4.2b). Specifically, the collagen type I 
content in BMC group was significantly lower from that detected in GFP- and TGF-treated 
groups, respectively (P<0.001 and P=0.001, respectively, Tukey post hoc test), whereas there 
was no difference among GFP and TGF groups (P=0.482, Tukey post hoc test). 
The collagen type II content was significantly lower in BMC and GFP treatment groups when 
compared with native cartilage (Figure 4.2c). There was no difference between the GFP and 
BMC groups (P=0.079, Tukey post hoc test). Collagen type II content in the TGF group was 
significantly higher (F2,19=56.2, P<0.001, one-way ANOVA; Figure 4.2c) than that detected 
in GFP- and BMC-treated groups (P<0.001 for both, Tukey post hoc test). 
When compared with native cartilage, water content in the repaired tissue was significantly 
lower in the TGF and GFP groups (P<0.001 and P=0.005, respectively, paired samples t-test; 
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Figure 4.2d), whereas the water content of the TGF group was significantly lower than those 
detected in the GFP (F2,19=5.9, P=0.01, one-way ANOVA; Figure 4.1d) and BMC groups 
(P=0.008, Tukey post hoc test). 
Biomechanical properties 
Cartilage stiffness at micrometer scale 
 Dynamic elastic modulus |E*| values for native articular cartilage and reparative cartilage 
obtained after treatment with gene plugs are shown in Figure 2. The measurements were 
obtained with a microspherical tip, nominal radius of 7.5 μm, and they reflect structural 
changes at the micrometer scale. |E*|micro values gradually increased from native cartilage to 
the TFG-, BMC- and GFP-treated groups (Figure 3a). |E*|micro was significantly higher in all 
repair groups when compared with native cartilage (BMC P<0.001, GFP P=0.003, TGF 
P<0.001, respectively, paired samples t-test). Treatment groups significantly differed in 
|E*|micro (F2,19=5.3, P=0.015; one-way ANOVA). |E*|micro from the TGF group was 
significantly lower than that detected in the GFP group (P=0.014, Tukey post hoc test). 
Values from the TGF group also appeared lower compared with those of the BMC group, but 
no statistically significant difference was observed.  
Figure 4.3: (a) Micrometer 
measurements. Dynamic elastic modulus 
|E
*
|micro of native articular cartilage and 
repair tissue of the BMC, GFP and TGF 
group. Average microstiffness (M±s.d.) 
increased from native cartilage to GFP-
treated group: |E*|micro=1.025±0.098 
(native cartilage), |E*|micro=1.577±0.285 
(TGF), |E*|micro=1.863±0.079 (BMC), 
|E*|micro=2.025±0.371 (GFP). *Two-tailed 
paired t-test comparison of repaired 
versus native cartilage (P<0.05). 
†
One-
way ANOVA with Tukey post hoc test 
comparison of repaired cartilage between 
treatment groups (P<0.05). (b) 
Nanometer measurements. Dynamic 
elastic modulus |E*|nano of native articular 
cartilage and repair tissue of the BMC, 
GFP and TGF group. |E*|nano =19.28±3 
(native cartilage), |E*|nano=21.54±1.24 
(BMC), |E*|nano=39.26±104.56 (TGF), 
|E*|nano=189.21±39.26 (GFP). 
*
Two-tailed 
paired t-test comparison of repaired and 
native cartilage (P<0.05). 
†
One-way 
ANOVA with Tukey post hoc test 
comparison of treatment groups (P<0.05). 
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There was a moderately positive association of |E*|micro with water and a moderately negative 
association with collagen type II, but no correlation with GAG and collagen type I content 
(Table 4.2). 
Table 4.2: Associations between dynamic elastic modulus measured on micrometer and 
nanometer scale and biochemical parameters (GAG, collagen I, collagen II, and water)  
Table 4.2.  
Association [Spearman's ρ(p)]  
|E*| micro  |E*| nano   
GAG −0.35 (0.108) −0.24 (0.288)  
Collagen I −0.08 (0.710) 0.80 (<0.001)a   
Collagen II −0.56 (0.007)a  0.29 (0.191)  
Water 0.44 (0.038)b  −0.46 (0.033)b   
 
 Abbreviation: GAG, glycosaminoglycan. 
a
 Association is significant at the 0.01 level (two-tailed). 
b
 Association is significant at the 0.05 level (two-tailed). 
 
Cartilage stiffness at nanometer scale 
Dynamic elastic modulus |E*| values for native articular cartilage and reparative cartilage are 
presented in Figure 4.3b. The measurements were obtained with sharp pyramidal tip, nominal 
radius of 20 nm, and they reflect structural changes at the nanometer scale. Obtained |E*|nano 
values suggested that the BMC-treated group had very similar stiffness to native cartilage 
(P=0.345, paired samples t-test), but that stiffness was higher in TGF- and GFP-treated 
groups (P=0.028 and P=0.005, respectively, paired samples t-test; Figure 4.3b). Furthermore, 
statistically significant differences in |E*|nano were found between treatment groups (P<0.001, 
Kruskall–Wallis test). Stiffness was significantly higher in the GFP control group than in the 
TGF group (P=0.007, Mann–Whitney test), whereas BMC had lower |E*|nano when compared 
with both GFP and TGF (P=0.001 and P=0.004, respectively, Mann–Whitney test). 
There was a strong positive association of |E*|nano with collagen I content and a moderate 
negative association with water content, but no correlation with GAG and collagen II content 
(Table 4.2). 
Polymerase chain reaction analysis 
To determine any expression levels from the gene transfer vectors within the synovial 
membrane 6 months after surgery, polymerase chain reaction (PCR) was performed using 
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primer sets recognizing the cytomegalovirus (CMV) promoter as well as sheep β-actin. The 
analysis included five groups of specimens according to treatment, namely TGF-β1 vector-
treated, GFP vector-treated as a transduction control, bone marrow treated, empty defect 
group and controls from contralateral knee. PCR analysis of the synovial tissue revealed no 
presence of the CMV promoter in any of the treatment groups or the control group 180 days 
after implantation. Expression of the β-actin gene was detected in all of the analysed samples. 
 
4.4 Discussion 
It is well known that the healing of focal lesions in adult articular cartilage is very limited 
and, over time, they may progress to osteoarthritis. Articular cartilage damage is a growing 
health care problem and a recent study showed that approximately two thirds of patients 
undergoing knee arthroscopies have been diagnosed with cartilage lesions[23]. On the other 
hand, the growing armamentarium of novel biological methods and technologies offer 
scientists and clinicians powerful tools for developing effective new methods in treating 
damaged cartilage. The cornerstones on which a successful tissue engineering-based strategy 
will likely be built include an adequate supply of repair cells, sufficient induction of those 
cells by growth factor signalling, and a biocompatible scaffold conducive to the repair 
process [24]. 
The approach to focal cartilage defect repair described in this study uses vector-laden 
coagulated bone marrow aspirates for gene delivery to the defect site. Aspirated autologous 
bone marrow contains progenitor cells, the matrix is completely natural and native to the 
host, and the constitutive fibrin fibres adhere the whole construct to the surface of the defect. 
Preliminary in vitro and in vivo studies on small animals showed that clotted mixtures of 
adenoviral suspensions with fresh aspirated bone marrow resulted in levels of transgenic 
expression in direct proportion to the density of nucleated cells within the clot [15]. This 
study is a step forward towards a clinical application of these gene plugs to treat local 
cartilage lesions. The whole study was conceived in a way to simulate potential clinical 
situation where one would have to treat isolated chondral defect situated on the load-bearing 
surface of the femoral condyle. Therefore, sheep were chosen for a large animal model. One 
drawback of the proposed model is the fact that sheep cartilage on the medial condyle is very 
thin. Ahern et al. [25] performed a detailed systematic review of preclinical animal models in 
single-site cartilage defect testing. According to their analysis, the ovine cartilage is variable 
in thickness and it measures from 0.40–1.68 mm. Minor variability in the obtained results 
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might be contributed to that fact, nevertheless, reproducible standardized chondral defects 
could be created in all animals, using an adapted punch-drill device. For implantation of the 
gene plugs, standard operation instruments were used. The proposed method proved to be a 
fairly straightforward technique for application in clinical settings. It is a single-step 
operation, which can be easily done by two surgeons within 30–45 min. 
The use of TGF-β1-transduced BMCs for articular cartilage defects repair 
Adult MSCs present a very interesting platform for the development of treatment strategies in 
orthopaedic tissue engineering. They can be obtained relatively easily from various tissue 
sources such as bone marrow, fat and muscle, and under appropriate conditions they have the 
capacity of differentiation into various mesenchymal lineages including bone and cartilage 
[5,26]. Numerous in vitro studies showed that primary MSCs undergo chondrogenic 
differentiation when cultured in the presence of specific media supplements, including 
dexamethasone and certain extracellular biological cues [27,28]. 
TGF-β1 has been used as a key inductor of chondrogenesis in many in vivo and in vitro 
studies, as it stimulates cell proliferation and synthesis of major components of ECM, GAG 
and collagen [29,30,31]. It was chosen for use in this study because it is one of the best 
characterized and most potent chondrogenic growth factors. The results of this study showed 
that all groups that underwent transplantation of BMCs have a high content of GAGs, but 
only the repair tissue from defects treated with TGF-β1 gene plugs had a very high content of 
collagen type II similar to native cartilage. The fact that only TGF-treated defects scored 
statistically higher in terms of columnar cellular distribution suggests that residing 
mesenchymal progenitors within the gene plug responded to the local expression of TGF-β1 
in terms of chondrogenic differentiation, which ultimately resulted in higher ECM turnover 
and better quality of the cartilage repair. Guo et al [32] reported similar results in a rabbit 
model of full-thickness cartilage defects using an ex vivo approach and a chitosan scaffold. 
Another study by Pagnotto et al. [33] showed improved cartilage repair in osteochondral 
defects implanted with MSCs transduced with adeno-associated virus (AAV) carrying cDNA 
for TGF-β1. In their study, transgene expression slowly decreased from 100% at 2 weeks to 
17% at 12 weeks, but it proved that gene therapy enables sustained delivery of the bioactive 
molecules for a period of time that is sufficient to induce and govern cellular response within 
the defect. Owing to its safe profile, AAV is considered to be the most suitable viral vector 
for human application, and is currently being tested in a phase I clinical trial [34]. 
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Integration of newly formed cartilage with and neighbouring, undamaged tissue has always 
been a major issue in cartilage repair. Poor integration causes uneven distribution of 
mechanical loading, and predisposes the joint surface to the development of early 
degenerative changes. Although certain improvement in integration was observed in TGF-
treated groups, the overall integration is far from being optimal. 
Considering that a number of biological factors act in a highly coordinated manner during 
native tissue development, the use of a single factor to stimulate and regulate process of 
chondrogenic differentiation, while practical, has limitations with regard to the producing 
cartilage of optimal quality. Chondrogenesis is a finely regulated process, which includes 
numerous growth and transcription factors, and a combination of these might be more 
effective. For example, synergistic effects on chondrogenesis have been reported for TGF-β1 
when co-administered with IGF-1 [35]. Steinert et al. [36] recently used an aggregate culture 
system to study effects of co-expression of TGF-β1, IGF-1 and BMP-2 on MSCs. Their 
results showed larger aggregates, higher levels of GAG synthesis and greater expression of 
cartilage specific marker genes by adding different combinations of growth factors. 
Furthermore, it is known that TGF stimulation of MSCs promotes hypertrophy and the 
increased expression of collagen type I and X. However, Kafienah et al.
 
[37] have shown that 
including parathyroid hormone-related protein downregulates collagen type I and X in 
cartilage tissue engineered from MSCs. It should be also noted that some transcription factors 
such as Sox-9 (which is known to be essential for the full expression of chondrocyte 
phenotype) and Wnt are not chondrogenic itself, but can make cells more responsive to 
growth factors and other chondrogenic stimuli. Along these lines, to optimize the proposed 
method, delivery of multiple genes might be more reliable option, and further studies are 
needed to pinpoint the exact protocol in terms of concentration and temporal sequence of 
delivery of chosen genes. 
Another important drawback to our study was the fact that we were not able to control 
weight-loading conditions in the operated animals. Inconsistencies in repair quality within the 
treatment groups could be attributed to the influence of the weight-loading conditions of the 
joint immediately after the surgical procedure. In human patients, proper rehabilitation 
protocols are crucial to optimize the results of bone marrow stimulating as well as cell-based 
techniques, including postoperative continuous passive motion exercises along with crutch-
assisted restrictions of weight-bearing up to 6–8 weeks [38,39]. Practical limitations 
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prevented postoperative ambulation restrictions, possibly allowing detrimental shear forces 
on the construct and leading to a reduced quality of produced matrix. These limitations might 
be reflected in the fact that TGF-treated groups had good concentrations of GAGs and 
collagen II, but very high content of collagen I and low content of water. 
Determining biomechanical properties of cartilage repair tissues by indentation-type 
atomic force microscopy 
Biochemical and histological parameters provide information regarding the amount and 
spatial distribution of the major components comprising repaired cartilage. However, only 
biomechanical analysis can assess the load-bearing capabilities of the cartilage and therefore 
biomechanical parameters reflect the functionality of the repaired tissue. To determine load-
bearing capabilities of examined tissue, indentation-type atomic force microscopy (IT AFM) 
was used to determine stiffness—a mechanical parameter that describes the relation between 
an applied, nondestructive load and resultant viscoelastic deformation of cartilage tissue. 
Furthermore, biomechanical data with biochemical content was correlated. 
Hyaline cartilage is highly specialized tissue with unique three-dimensional structure, which 
allows it to behave mechanically as a viscoelastic solid [40]. This reflects the unique 
ultrastructure of cartilage ECM, which is composed of proteoglycans embedded into a 
network of different types of collagen fibrils. Under cyclic loading, the applied stress and 
resulting strain are not in phase. To determine stiffness of the cartilage, compressive force is 
applied and the ratio of stress to strain, the dynamic elastic modulus |E*|, is calculated. 
Several studies describe the use of probes of varying shape for indentation testing of cartilage 
where data are typically assessed at millimeter scale. However, this is insufficient to detect 
local mechanical property variations of the examined tissue that reflect differences in 
cartilage structural organization at the molecular level [41,42]. 
To overcome these limitations, Stolz et al.
 
[22] proposed a novel, AFM-based approach they 
termed IT AFM. Their protocol enabled absolute measurements of the dynamic elastic 
modulus |E*| at two different length scales of tissue organization—micrometer and 
nanometer. This is technically possible because two different probe types are used for these 
measurements: the microspherical tips for micrometerscale measurements, and sharp 
pyramidal tips for nanometerscale measurements. In our study, dynamic elastic modulus 
|E*|nano of the native sheep cartilage is ~0.02 MPa, and |E*|micro is ~1 MPa, which is in 
agreement with studies performed on human cartilage, where stiffness values averages 
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around 0.015 and 2.6 MPa, respectively, for healthy individuals without OA [43,44]. 
According to Stolz et al., this 100-fold modulus difference between micrometer and 
nanometer scale is a result of assessing different levels of cartilage hierarchical organization. 
On the micrometer scale, articular cartilage behaves as relatively amorphous material, 
whereas at the nanometer scale, ultrastructural differences are resolved. 
Microstiffness values were lowest for native cartilage and gradually rose from TGF- and 
BMC- to GFP-treated groups, respectively (Figure 4.2). This would suggest that the repair 
tissue of the TGF-treated group is qualitatively superior to the other two groups showing 
biomechanical properties close to native cartilage. However, nanoscale measurement showed 
that the BMC-treated group has very similar nanostiffness to that of native cartilage, and the 
stiffness values of the TGF- and GFP-treated groups are much higher (Figure 4.3). We 
hypothesized that this observation could reflect different amounts and spatial orientation of 
newly synthesized extracellular components and/or water content within the repair tissue in 
the last two groups. To test this hypothesis, correlation analysis was performed, which 
showed that the dynamic elastic modulus |E*|micro correlated moderately positively with water 
and moderately negatively with collagen type II, but not with GAG and collagen type I 
content (Table 4.2). At the same time, |E*|nano correlates strongly positive with collagen type I 
and moderately negative with water, but not with GAG and collagen type II content (Table 
4.2). At the micrometer level, biomechanical properties of cartilage repair tissue are only 
moderately correlated with the biochemical content. This observation leads us to conclusion 
that, at micrometer level of tissue organization, it is not possible to determine contribution of 
individual ECM components to biomechanical properties of repaired cartilage. However, at 
the nanometer level, dynamic elastic modulus correlates with collagen I content, which is 
barely present in native cartilage. A sharp AFM tip has nominal radius of 20 nm that is 
smaller than an individual collagen fibril, which typically measures around 50 nm.
22
 
Although microspherical tip is too big to detect subtle differences in orientation and amount 
of collagen fibrils, sharp pyramidal tip can discriminate such differences, resulting in higher 
stiffness values. 
Presence of adenoviral vector in the surrounding synovial lining 
The use of viral-based gene therapy is controversial with regards to safety. Although very 
effective in terms of gene transfer and expression, viral vectors induce immune response and 
their presence in the surrounding tissue may result with detrimental side effects. For example, 
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TGF-β1 administered into the joint in sufficient concentrations can lead to chondrophyte 
formation at the joint margins, which at later stages calcify and become real osteophytes [45]. 
One of the major goals of this study was to determine whether there is any residual presence 
of virus within the synovium. After killing the animals, joints were inspected for any signs of 
osteophyte formation and/or arthrofibrosis, but none was detected. Although PCR analysis of 
the synovial lining tissue could not detect the residual presence of transgene in any of the 
experimental groups, suggesting that the virus is well contained within the clot, this 
information should be taken cautiously. Given what is known about the immune response to 
adenovirus and adenovirally modified cells, it is possible that any modified cells within the 
synovial tissue were cleared after 6 months. Future studies should use additional procedures, 
such as measure of elevated cytokines from lavage fluid during the first weeks following 
surgery, as a more sensitive indication of undesired side effects within the joint. The next 
generation of improved gene vehicles, such as those based on recombinant AAV (rAAV), 
might be more suitable for cartilage repair than the first generation adenoviral vectors used in 
this study. In comparison to adenovirus, rAAV is less immunogenic, and the reduced risk of 
adverse reactions is a substantial advantage favouring the use of this class of vector [20]. 
In conclusion, this study systematically explored the benefits and pitfalls of the novel 
technique to treat local cartilage defects by using gene plugs in clinical settings. In contrast to 
more complex approaches in tissue engineering, we advocate the use of simpler methods that 
harness the intrinsic regenerative potential of endogenous tissues, using biological stimuli to 
initiate and promote natural healing in situ. This concept has been termed facilitated 
endogenous repair by Evans et al.
 
[46] and the ultimate goal is to enable clinicians to use 
tissue engineering that is not only successful but also cheap, safe and clinically expeditious. 
The proposed method is a single-step procedure that can be easily implemented in standard 
clinical settings, avoids the usual drawbacks associated with gene therapy because it is 
administered locally, and excludes the expensive in vitro production of autologous and 
engineered tissues. 
4.5 Materials and Methods 
Vector construction 
The first generation recombinant vectors used in this study originated form replication-
deficient type 5 adenovirus lacking E1 and E3 loci (Ad.).16 Vectors directing overexpression 
of TGF-β1 (Ad.TGF-β1) and Ad.GFP—each driven by the CMV promoter—were 
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constructed by Cre-lox recombination using the system of Hardy et al.17 These adenoviral 
vectors were propagated in 293-CRE8 cells and purified on three successive CsCl2 density 
gradients between 1.2 and 1.4 g ml−1. Following dialysis in 10 mM Tris-HCL, pH 7.8, 
150 mM NaCl, 10 mM MgCl2 and 4% sucrose, the preparations were aliquotted and stored at 
−80 °C. Viral titers were estimated by optical density and standard plaque assay. 
 
Animals 
Twenty-eight skeletally mature sheep (female, 1–3 years old) were used for this study. The 
sheep were randomly assigned to one of the four groups. In the BMC group (n=6), the sheep 
were implanted with untreated autologous BMC that was aspirated from iliac crest of 
respective animal. In the GFP group (n=6), autologous BMCs genetically modified with 
Ad.GFP were implanted in sheep as a vector control. In the TGF-β1-treated (TGF) group 
(n=10), autologous BMCs genetically modified Ad.TGF-β1 were implanted in the sheep. In 
the negative control (CON) group (n=6), defects were left empty. Native cartilage from the 
contralateral knee was harvested from each animal and compared with the repair tissue of the 
defect sites. The experimental protocol was approved by the local Animal Experiment Ethical 
Committee. 
 
Anaesthesia protocol 
The sheep were operated on under general anaesthesia and aseptic conditions. The 
premedication was performed with 0.1 mg kg−1 of intramuscular xylazine (Xylapan, 
Vetoquinol, Bern, Switzerland) and cephalic vein was prepared for administration of drugs. 
Induction of anaesthesia was performed intravenously with 2.5% solution of thiopentale 
sodium (Thiopental, Nycomed, Ismaning, Germany) in a dose 5 mg kg−1 and small boluses 
of drug were administered until the jaws were relaxed for endotracheal intubation. 
Cefuroxime (Ketocef, Pliva, Zagreb, Croatia) was administered perioperatively. Carprofen 
(Rymadil, Pfizer Animal Healthcare, Exton, PA, USA) was administered postoperatively in a 
dose of 2 mg kg−1. 
 
Surgical procedure 
Medial parapatellar arthrotomy was performed on the right knee of each animal, and both 
condyles were exposed. A standardized partial-thickness chondral defect of 6.2 mm in 
diameter (Figures 4a and b) was made on the weight-bearing surface of the medial condyle 
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using a punch-drill device adapted from mosaicplasty instrumentation (Smith & Nephew Inc., 
Andover, MA, USA). Special care was taken not to damage the subchondral bone, as well as 
to create sharp edges at the border of the defects that were perpendicular to the joint surface. 
Defects were then treated as described below. 
 
 
Figure 4.4 Implantation of a gene plug. (a) An adaptation of standardized mosaciplasty instrumentation was 
used to create a chondral defect on the weight-bearing surface of the medial condyle in sheep. (b) Care was 
taken not to penetrate the subchondral plate. The defect measured 6.2 mm in diameter. (c) Pressfit implantation 
of the bone marrow construct into the defect. (d) The plug is stable and well placed within the defect. The joint 
is rinsed with saline and ready to be closed. 
 
Press-fit implantation of gene plugs and native bone marrow plugs into the defects 
Under sterile surgical conditions, 3 ml of bone marrow was aspirated form the right iliac crest 
of an anaesthetized sheep using a TrapsystemSet (H-S Medical Inc., Boca Raton, FL, USA) 
and a 16-g needle. Using a 1-ml micropipette, aliquots of 250 μl were rapidly mixed with 
25 μl suspension of 1 × 1010 viral particles of Ad.GFP or Ad.TGF-β1. The mixtures were 
pipetted into the defects and immediately covered with a paper to build a chamber and allow 
coagulation in situ for 5 min. The paper was then removed, and the implants were rinsed with 
saline solution and checked for stability by repetitive flexion and extension of the knee. The 
joint was closed by suturing in two layers (Figures 4.4c and d). 
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Gene transfer to BMCs for in vitro culture 
A portion of bone marrow aspirate obtained from iliac crest (as described in previous 
paragraph) was used to generate genetically modified BMCs for in vitro culture. Using a 1-ml 
micropipette, aliquots of 250 μl of bone marrow aspirate were rapidly mixed with 25 μl 
suspension of 1 × 1010 viral particles of Ad.GFP. Following coagulation, the BMCs were 
removed from the vessel, and placed in individual wells of 24-well plates with 0.5 ml of 
DMEM with 10% FBS and 1% penicillin/streptomycin. Media were replaced every 3 days. 
Clots were maintained in this manner for 21 days until analysed with fluorescence 
microscopy. Native BMCs were used as negative controls. This parallel set of in vitro 
cultures served as indirect proof of transgenic expression within the transplanted gene plugs. 
 
Harvesting the samples 
Six months after surgery, all sheep were killed by intravenous injection of an overdose of 
barbiturate. The medial condyle containing the cartilage defect was removed and divided into 
two halves using a cooled saw: one being used for histology and one for biochemistry and 
biomechanical testing. Undamaged articular cartilage was taken from the medial condyle of 
the contralateral knee joint for comparison with treated condyles. The specimens for 
histology, biochemical and biomechanical analysis were prepared as described below. 
Synovial lining specimens were also taken from each joint and stored in liquid nitrogen for 
PCR analysis. 
 
Morphologic analysis—histology 
The osteochondral samples fixed for histology were decalcified in 10% 
ethylenediaminetetraacetic acid. The samples were dehydrated in alcohol, embedded in 
paraffin and sectioned at 5 μm. Sections were stained with haematoxylin and eosin to 
evaluate morphology, and safranin-O to assess proteoglycan distribution in the pericellular 
matrix. Slides were examined by two blinded observers using light microscopy and graded 
semiquantitatively using the ICRS Visual Histological Assessment Scale [18]. The scoring 
system was based on articular surface morphology, matrix composition, cellular distribution, 
cell population viability, subchondral bone morphology and cartilage mineralization. 
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Quantitative biochemical characterization 
Samples were frozen and stored at −80 °C until ready for analysis. Wet and dry weights of the 
cartilage or repair tissue were determined before and after freeze drying. The samples were 
then solubilized using digestion with trypsin and processed for complete biochemical 
analysis, as described by Dickinson et al [19].  
Each sample was milled in liquid nitrogen using a stainless steel percussion mortar and 
pestle, to obtain a fine particulate, and weighed after freeze drying to obtain the dry weight. 
Bovine pancreatic trypsin was prepared at 2 mg ml−1 in Tris buffer (pH 7.5) containing 1 mM 
iodoacetamide, 1 mM ethylenediaminetetraacetic acid and 10 mg ml−1 pepstatin A (all from 
Sigma-Aldrich, St Louis, MO, USA). An initial incubation for 15 h at 37 °C with 250 ml 
trypsin was followed by further 2 h incubation at 65 °C after the addition of a further 250 ml 
of the freshly prepared proteinase. All samples were boiled for 15 min at the end of 
incubation to destroy any remaining enzyme activity. 
 
Type I collagen 
 The digests were assayed using inhibition enzyme-linked immunosorbent assay using a 
rabbit antipeptide antibody to type I collagen, as described earlier [19].  
 
Type II collagen 
 The digests were assayed using inhibition enzyme-linked immunosorbent assay using a 
mouse immunoglobulin G monoclonal antibody to denatured type II collagen, COL2–3/4 m, 
as described earlier, but modified for use on 384-well plates to allow the use of a smaller 
volume of sample than is required for a 96-well plate [20].  
 
Glycosaminoglycans 
 A previously described colorimetric assay for GAG was modified for use on 384-well plates 
to allow the use of a smaller volume of sample than is required for a 96-well plate [19,21]. 
  
Water content 
The percentage of water was calculated by subtracting the dry weight of the sample and 
dividing the difference by the wet weight. 
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PCR analysis 
To detect the presence of adenoviral genome in the synovial lining, PCR analysis was 
performed. Synovial membranes of the joints were digested with proteinase K for 4 h at 
37 °C. Total DNA was then extracted using a DNeasy Tissue kit (Qiagen, Valencia, CA, 
USA), following the manufacturer's instructions. Amplification of the CMV promoter 
sequence within the vectors as well as the sheep β-actin gene was performed using the 
following primers: CMV forward 5′-TCATATGCCAAGTACGCCCCC-3′, reverse 5′-
TGGGGCGGAGTTGTTACGAC-3′; β-actin forward 
5′CATGCCATCCTGCGTCTGGACC-3′, β-actin reverse 5′ 
TACTCCTGCTTGCTGATCCACATCTGC-3′. Amplification products were visualized on 
agarose gel with ethidium bromide. 
 
Biomechanical properties 
Biomechanical properties of the repair tissue compared with regular cartilage from the 
contralateral knee was assessed by IT AFM of 2 mm diameter samples, harvested using a skin 
biopsy punch and scalpel. Care was taken to include the full thickness of the repair tissue but 
to exclude any subchondral bone. The specimens were then stored in the cold room at 4° 
Celsius in PBS supplemented with protease inhibitor cocktail (Complete, Boehringer 
Mannheim, Germany). 
Mechanical properties (that is, stiffness) of articular cartilage and repair tissue were 
determined by measurements of |E*|, the dynamic elastic modulus of articular cartilage, at 
two different length scales of tissue organization: micrometer (|E*|micro) and nanometer 
(|E*|nano). Preparation of the cartilage samples, data acquisition and processing was done as 
described by Stolz et al.[22] Briefly, spherical tips with radius of 7.5 μm (SPI Supplies, West 
Chester, PA, USA) were mounted onto the end of rectangular tipples silicon nitride 
cantilevers having nominal spring constants of 0.35 N m−1 (MicroMasch, San Jose, CA, 
USA) and used for micrometer-scale experiments. For nanometer-scale experiments, square-
based pyramidal silicon-nitride tips with a nominal tip radius of 20 nm were used on V-
shaped 200-mm-long silicon nitride cantilevers with a nominal spring constant of 0.06 N m−1 
(Veeco Instruments Inc., Plainview, NJ, USA). The IT AFM was operated in the force-
volume mode, where the load–displacement curves were recorded at five different sites on 
the sample surface at a frequency of 3 Hz with scan areas of 0 × 0 μm and 10 × 10 μm. Data 
sets recorded at any given sample site consisted of 256 load–displacement curves (each curve 
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consisting of 512 data points), which were analyzed to compute the dynamic elastic modulus 
|E*|. 
 
Statistics 
A Kolmogorov–Smirnov test was used to test distributions of biochemical (GAG, collagen I, 
collagen II and water) and biomechanical data (|E*|micro and |E*|nano) for normality. 
Distributions were normal for all data sets except for |E*|nano. Therefore, parametric tests 
were used to analyse all biochemical and biomechanical data, whereas elastic modulus data 
were analysed by nonparametric testing. Biochemical and biomechanical properties of 
repaired cartilage were expressed as the mean (M) ± s.d. As the contralateral knee in each 
animal served as its own control, a two-tailed paired samples t-test was used to compare 
treatment versus control groups. Data from each test subsets were compared by one-way 
ANOVA with Tukey post hoc test where required. To analyse |E*|nano, results, we used 
Wilcoxon matched pairs test as a nonparametric equivalent of the paired samples t-test and 
Kruskal–Wallis and Mann–Whitney tests as equivalents of ANOVA and Tukey post hoc. 
Nonparametric tests were also used to analyse semiquantitative histological scores. 
Association between biomechanical properties and biochemical content were determined 
using Spearman correlation. Statistical significance was set at P<0.05. All analyses were 
performed using SPSS 17.0 for Windows (SPSS Inc., Chicago, IL, USA). 
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5.1 Abstract 
Introduction 
Oxygen is a critical parameter proposed to modulate the functions of chondrocytes ex-vivo as 
well as in damaged joints. This article investigates the effect of low (more physiological) 
oxygen percentage on the biosynthetic and catabolic activity of human articular chondrocytes 
(HAC) at different phases of in vitro culture. 
 
Methods 
HAC expanded in monolayer were cultured in pellets for two weeks (Phase I) or up to an 
additional two weeks (Phase II). In each Phase, cells were exposed to 19% or 5% oxygen. 
Resulting tissues and culture media were assessed to determine amounts of produced/released 
proteoglycans and collagens, metalloproteinases (MMPs), collagen degradation products and 
collagen fibril organization using biochemical, (immuno)-histochemical, gene expression and 
scanning electron microscopy analyses. In specific experiments, the hypoxia-inducible factor-
1α (HIF-1α) inhibitor cadmium chloride was supplemented in the culture medium to assess 
the involvement of this pathway. 
 
Results 
Independent from the oxygen percentage during expansion, HAC cultured at 5% O2 (vs 19% 
O2) during Phase I accumulated higher amounts of glycosaminoglycans and type II collagen 
and expressed reduced levels of MMP-1 and MMP-13 mRNA and protein. Switching to 19% 
oxygen during Phase II resulted in reduced synthesis of proteoglycan and collagen, increased 
release of MMPs, accumulation of type II collagen fragments and higher branching of 
collagen fibrils. In contrast, reducing O2 during Phase II resulted in increased proteoglycan 
and type II collagen synthesis and reduced expression and release of MMP-13 mRNA and 
protein. Supplementation of cadmium chloride during differentiation culture at 5% O2 
drastically reduced the up-regulation of type II collagen and the down-regulation of MMP-1 
mRNA. 
 
Conclusions 
The application of more physiologic oxygen percentage during specific phases of 
differentiation culture enhanced the biosynthetic activity and reduced the activity of catabolic 
enzymes implicated in cartilage breakdown. Modulation of the oxygen percentage during 
HAC culture may be used to study pathophysiological events occurring in osteoarthritis and 
to enhance properties of in vitro engineered cartilaginous tissues. 
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5.2 Introduction 
Homeostasis of normal cartilage in adults represents a delicate balance between the synthesis 
and the degradation of extracellular matrix components to maintain the functional integrity of 
the joint. In elderly individuals, together with changes in proliferation activity, energy 
metabolism and response to growth factors [1], chondrocytes become less resistant to 
extrinsic stress. This in turn causes a disturbance of tissue homeostasis and thus the risk of 
degenerative pathologies of osteoarthritic nature [2]. In particular the oxidative stress is 
proposed to play a key role in cartilage degeneration. 
Oxygen is a critical parameter proposed to modulate chondrocyte metabolic activity [3]. 
Indeed, articular cartilage is generally exposed to a finely regulated gradient of relatively low 
oxygen percentages (from about 10% at the surface to about 1% in the deepest layers) [4], 
which is essential for maintenance of specialized tissue function [5]. During the onset of 
cartilage degeneration, possibly due to surface fibrillation and/or microfractures of the 
subchondral bone, such gradients have been proposed to break down [6], thus contributing to 
the progression of the disease. 
The influence of various oxygen percentages on chondrocyte function has been investigated 
in a broad variety of models, differing with respect to (i) the cell source used (species: 
bovine, chicken, rodents, human, and anatomical locations of cell harvesting: knee, hip, 
interphalangeal joint, nose), (ii) the characteristic of the donor (age, stage of cartilage 
degeneration), (iii) the oxygen percentage applied (from less then 1% to more than 60%), (iv) 
the hydrodynamic culture conditions (static culture or mixing within bioreactors), and (v) the 
stage of cell differentiation (cells in native tissue, de-differentiated cells, re-differentiating 
expanded cells in pellets, alginate gels, or different types of porous scaffolds). It is thus not 
surprising that the data reported in literature on the influence of oxygen percentage on 
chondrocyte behavior are rather controversial [3]. For instance, as compared to culture under 
normoxic conditions (18 to 21% oxygen), culture at more physiological, low oxygen 
percentages (1 to 8%) has been reported to increase [7-10], decrease [11,12] or have no effect 
on the chondrocyte proliferation rate [6,13-15]. Moreover, the expression of cartilage specific 
genes and/or the extent of matrix protein synthesis/deposition was reported to be up-regulated 
[6-9,12,15-22], down-regulated [10,23-26] or not modulated at all [6,9] by culture under 
more physiological oxygen percentages. 
Importantly, in addition to the still controversial findings, in the above mentioned studies the 
effect of oxygen percentage on chondrocytes has mainly been investigated with regard to the 
cell biosynthetic activity, without considering and exploring chondrocyte catabolic processes. 
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We thus aimed our study at investigating the effect of a low (more physiological) oxygen 
percentage both on the cartilage tissue forming capacity of human articular chondrocytes 
(HAC), and on their pro-catabolic, matrix degradative activity. In particular, we hypothesized 
that culture at a more physiological oxygen percentage has a dual role in the chondrocyte 
metabolism, by enhancing their biosynthetic activity and at the same time reducing the 
expression of matrix degradative enzymes. To test these hypotheses, HAC were exposed to 
normoxic conditions (19%) or to a low oxygen percentage (5%) during culture in two simple 
and widely used model systems (that is, monolayer expansion or differentiation in micromass 
pellets), as well as at different phases of tissue development (that is., during de-novo tissue 
formation or in pre-formed tissues). We further investigated whether the applied oxygen 
percentage influences the structural organization of the collagen fibrils produced by HAC and 
whether those features have a pathophysiological counterpart in healthy and osteoarthritic 
cartilage tissue. Finally, in order to address whether the metabolic effects of HAC culture at 
low oxygen percentage involve signaling through the hypoxia-inducible factor-1α (HIF-1α) 
pathway, some cultures were supplemented with the specific inhibitor cadmium chloride. 
 
5.3 Materials and Methods  
 
Cartilage samples collection 
Macroscopically normal human articular cartilage samples (Mankin Score: 2 to 3) were 
obtained post mortem (within 24 hours after death) from the knee joints of a total of six 
donors with no clinical history of joint disorders (mean age: 56 years, range: 43 to 65 years), 
after informed consent by relatives and in accordance with the local ethics committee 
(University Hospital Basel, Switzerland). Cells from different donors were used for 
independent experimental runs. Osteoarthritic cartilage tissues (Mankin Score: 6 to 7) 
harvested from three patients undergoing total or partial knee replacement (female:male = 
2:1, mean age: 67 years, range 65 to 71 years) were used as controls for degenerated 
structural organization of collagen fibrils. 
 
Chondrocyte isolation and expansion 
Cartilage tissues were minced in small pieces and digested with 0.15% type II collagenase 
(10 ml solution/g tissue) for 22 hours. The isolated human articular chondrocytes (HAC) 
were expanded for two passages with Dulbecco's Eagle's Medium (DMEM) containing 4.5 
mg/ml D-glucose, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 100 mM 
HEPES buffer, 100 U/ml penicillin, 100 μg/ml streptomycin and 0.29 mg/ml L-glutamate 
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supplemented with 10% of foetal bovine serum (complete medium) and 1 ng/ml of 
Transforming Growth Factor β1 (TGFβ-1), 5 ng/ml of Fibroblast Growth Factor 2, and 10 
ng/mL of Platelet-Derived Growth Factor-BB (all from R&D Systems, Minneapolis, MN, 
USA) (expansion medium) [27] in a humidified incubator (37°C/5% CO2) at either normoxic 
condition (19% O2) or low, more physiological oxygen tension (5% O2). Expansion medium 
was equilibrated under 5% and 19% O2 for at least six hours before each media change. 
Expanded cells were subsequently cultivated in pellets as described below. 
 
3D pellet cultures 
The chondrogenic capacity of expanded HAC was investigated in pellet cultures under the 
two oxygen conditions (19% O2 and 5% O2) used for the expansion. Chondrocytes were re-
suspended in complete medium supplemented with 10 μg/ml insulin (ACTRAPID HM), 0.1 
mM ascorbic acid 2-phosphate (SIGMA, San Gallen, Switzerland), 10 ng/mL Transforming 
Growth Factor-β3 (Novartis, Basel, Switzerland) (chondrogenic medium) [27]. Chondrogenic 
medium was equilibrated under 5% and 19% O2 for at least six hours before each media 
change. 
Pellets generated by cells from two donors after two weeks of culture under the two oxygen 
percentages (19% O2 or 5% O2) (Phase I) were further cultured for up to two weeks (Phase II) 
in chondrogenic medium at the same or at interchanged oxygen percentages (that is, from 5% 
to 19% O2 or from 19% to 5% O2) (Figure 5.1). For the HIF-1α inhibition experiments, 
pellets generated by cells from three donors after two weeks of culture at 19% O2 were 
subsequently exposed to 5% O2 and cultured for six hours or three days in chondrogenic 
medium supplemented with 5 μM cadmium chloride (CdCl2, SIGMA) [28]. 
Resulting tissues were analyzed histologically, immunohistochemically, biochemically and 
via scanning electronic microscopy to determine the quality of generated tissue, anabolic and 
catabolic cell functions and collagen fibril organization. 
 
 
 
Chapter 5: The influence of various oxygen percentages on chondrocytes function 
 
106 
 
 
Figure 5,1: Experimental design. Human articular cartilage were cultured in monolayer (Expansion) under 5% 
and 19% oxygen percentages. Cells were then cultured for two weeks again under the two oxygen percentages 
(Differentiation Phase I). Pellets generated at 5% and 19% oxygen were further cultured at the same conditions 
or at interchanged oxygen percentages (Differentiation Phase II). 
 
Pellet characterization 
Biochemical analyses 
For the determination of the glycosaminoglycan (GAG) and DNA contents, pellets were 
digested with protease K (0.5 ml of 1 mg/ml protease K in 50 mM Tris with 1 mM EDTA, 1 
mM iodoacetamide, and 10 μg/ml pepstatin-A for 15 hours at 56°C) as previously described 
[29]. GAG contents of pellets were measured spectrophotometrically using the 
dimethylmethylene blue (DMMB) assay [30]. The DNA amount was measured 
spectrofluorometrically using the CyQUANT
® 
Kit (Molecular Probes, Eugene, OR, USA) 
following the kit's instruction. GAG contents were reported as μg GAG/μg DNA. 
 
Measurement of [
35
S]SO4 and [
3
H]proline incorporation 
The proteoglycan and collagen synthesis of pellets were measured by assessing the 
incorporation of (
35
S)SO4 and (
3
H)proline for a period of 24 h as described previously [31]. 
Briefly, pellets were incubated in the presence of both (
35
S)SO4 (1 μCi/culture) to label 
proteoglycans and (
3
H)proline (1.5 μCi/culture) to label collagen. For the assessment of the 
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released ECM fraction, radiolabeled proteoglycan and collagen were precipitated overnight at 
4°C using respectively 100% ethanol and 70% ammonium sulphate and subsequently, 
resuspended in 4 M guanidine hydrochloride or 10% sodium dodecyl sulphate in Tris buffer 
(0.1 M, pH 7.0) respectively for proteoglycan and collagen. For the assessment of the 
incorporated ECM fraction, tissue pellets were digested with protease K as previously 
described. The incorporation of (
35
S)SO4 and (
3
H)proline in culture pellet and in conditioned 
medium was measured in a Packard β-liquid scintillation counter with scintillation fluid 
(Ultima Gold, Perkin Elmer, Schwerzenbach, Switzerland). The amount of synthesised 
molecules was normalized to the DNA content of the tissue. 
 
Histological and immunohistochemical analyses 
Pellets were fixed in 4% formalin, embedded in paraffin and cross-sectioned (5 μm thick 
sections). The sections were stained with Safranin O for sulfated GAG and processed for 
immunohistochemistry to visualize type II collagen (II-II6B3, Hybridoma Bank, University 
of Iowa, Iowa City, IA, USA), as described in Grogan et al. [32] and type II collagen 
fragments according to Roy-Beaudry et al. [33]. 
 
Electronic microscopy (SEM) 
Images obtained from both scanning electron microscopy (SEM) and transmission electron 
microscopy (TEM) were used for the structural analysis of collagen fibrils. Pellet samples 
were glued onto a Teflon disc with a five-minute curing epoxy glue (Devcon Epoxy, ITW 
Brands, Wood Dale, IL, USA). After which, the mounted specimens were placed in a 
vibratory microtome (VT 1000 E, Leica, Heidelberg, Germany) to trim off the outermost, 
approximately 150 μm thick cartilage layer parallel to the support surface to minimize 
inhomogenities across the surface among samples. The surface layer of the adult healthy and 
OA cartilage was examined without any modification. The samples were then prepared for 
SEM and TEM analysis as previously described [34]. For TEM analysis, the samples were 
further homogenised into small pieces in order to isolate single collagen fibrils. 
 
Image analysis 
Quantitative data on the collagen fibril organization were obtained using the Image 
Processing Library & Toolbox (IPLT) image analysis software package (Basel, Switzerland) 
[35]. A Canny edge detection algorithm [36], followed by a skeletonization algorithm [37] 
was applied to identify the collagen fibrils. The skeletonized data were subjected to an 
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algorithm identifying the end points and intersections of the skeleton. Using this information, 
the individual line segments were identified and analyzed. Finally, the following parameters 
were determined from each pellet condition: (i) the bending ratio, calculated as the mean-
squared end-to-end distance divided by the mean-squared contour length and (ii) the 
persistence length, calculated using a previously described model [38]. Both these parameters 
were required to correlate the linearity of the fibrils and length before branching of each 
individual fibril to its mechanical properties, respectively [39]. 
 
Total RNA extraction and cDNA synthesis 
Total RNA of pellets was extracted using Trizol (Life Technologies, Basel, Switzerland) and 
the standard single-step acid-phenol guanidinium method. RNA was treated with DNAseI 
using the DNA-free™ Kit (Ambion, Austin, Texas) and quantified spectrometrically. cDNA 
was generated from 3 μg of RNA by using 500 μg/ml random hexamers (Promega AG 
Dübendorf, Switzerland) and 1 μl of 50 U/ml Stratascript™ reverse transcriptase (Stratagene, 
Amsterdam, NL), in the presence of dNTPs. Real-time RT-PCR reactions were performed 
and monitored using the ABI Prism 7700 Sequence Detection System (Perkin-Elmer/Applied 
Biosystems, Rotkreuz, Switzerland). Cycle temperatures and times as well as primers and 
probes used for the reference gene (18-S rRNA) and the genes of interest (collagen type II 
and aggrecan) were as previously described [40]. Assays on-Demand (Applied Biosystem) 
were used to measure the expression of MMP-1 (Hs00233958_m1), MMP-2 
(Hs00234422_m1), MMP-9 (Hs00234579_m1) and MMP-13 (Hs00233992_m1). For each 
cDNA sample, the threshold cycle (Ct) value of each target sequence was subtracted to the Ct 
value of 18-S rRNA, to derive ΔCt. The level of gene expression was calculated as 2ΔCt. Each 
sample was assessed at least in duplicate for each gene of interest. 
 
Quantification of released matrix metalloproteinases 
Matrix metalloproteinases (MMP) were quantified in media collected from cultured pellets 
by using the MultiAnalyte Profiling MMP base Kit (Fluorokine
® 
MAP: LMP000) 
complemented with the specific MMPs (MMP-1: LMP901; MMP-3: LMP513; MMP-9: 
LMP911; MMP-13: LMP511, R&D Systems, Minneapolis, MN, USA). The assay was 
performed on a Luminex 100™ analyzer (Austin, Texas, USA) following the manufacturer's 
instructions. The amount of released MMPs was normalized to the DNA content of the tissue. 
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Statistical analysis 
For each analysis, triplicate pellets for each condition and donor were assessed. Statistical 
evaluation was performed using SPSS software version 7.5 software (SPSS, Sigma Stat, 
Erkrath, Germany). Values are presented as mean ± standard deviation (SD). Differences 
between groups were assessed by Mann Whitney tests. Differences in the persistence length 
and bending ratio of collagen fibrils from different conditions were assessed by one-way 
analysis of variance (ANOVA) with Bonferroni post hoc test. Values of P < 0.05 were 
considered statistically significant. 
 
5.4 Results 
 
Chondrogenic differentiation of HAC cultured under different oxygen percentages 
HAC were initially cultured in monolayer with expansion medium at 5% or 19% O2 and 
subsequently re-differentiated in three-dimensional pellets at the two different oxygen 
percentages (Phase I) (See Figure 5.1 for the experimental design). HAC proliferated at 
comparable rates (less than 5% variation in the number of doublings/day; data not shown) at 
the two oxygen conditions. Cells expanded at either oxygen percentage and subsequently 
differentiated at 19% O2 produced tissues faintly stained for GAG and type II collagen 
(Figures 5.2A, I and 2II and 5.2B, I and 2II). Instead, reducing oxygen percentage during 
differentiation enhanced the amount of cartilaginous matrix accumulation, as evidenced by a 
qualitative increased size of the generated tissues (Figure 5.2A, low magnification), an 
increased intensity of Safranin O and type II collagen stain (Figure 5.2A, B) and a 
statistically significant higher amount of GAG (3.4- and 3.1-fold for HAC expanded at 19% 
or 5% O2 respectively) (Figure 5.2C). Due to the fact that expansion at 5% O2 did not 
influence the extent of HAC differentiation, further assessments were only performed with 
cells expanded at 19% O2. In agreement with the histological and biochemical results, the 
RT-PCR analysis confirmed statistically significant higher expression of the cartilage specific 
genes type II collagen (86.6-fold) and aggrecan (8.5-fold) at 5% O2 than at 19% O2 after the 
Phase I differentiation culture (Figure 5.2D, E). 
Chapter 5: The influence of various oxygen percentages on chondrocytes function 
 
110 
 
 
 
Figure 5.2:.Anabolic response of HAC to different oxygen percentages during the expansion and 
differentiation Phase I. (A - B) Safranin O and type II collagen immunohistochemical stainings of 
representative tissues generated by human articular chondrocytes (HAC) expanded at 19% (I and III) or 5% (II 
and IV) oxygen and further cultured in pellets at 19% (I and II) or 5% (III and IV) oxygen. Bar = 100 μm. (C) 
Quantification of glycosaminoglycans (GAG) accumulated normalized to the amount of DNA. (D - E) Real 
time reverse transcription-polymerase chain reaction analysis of the expression of type II collagen and aggrecan 
mRNA by HAC cultured in pellets at 19% and 5% O2. Levels are expressed as fold of difference from 
ribosomal 18S. For the gene expression analysis only expansion at 19% O2 was considered. Values are mean ± 
SD of measurements obtained from three independent experiments. * = significantly different from the 19% O2. 
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Expression of catabolic mediators 
We then investigated the possible role of oxygen percentage in modulating the expression of 
catabolic mediators. Analysis of specific matrix metalloproteinases (that is, MMP-1, MMP-2, 
MMP-9 and MMP-13) by RT-PCR indicated that low oxygen percentage applied during the 
Phase I differentiation culture selectively down-regulated MMP-1 and MMP-13 mRNA 
expression (7.7- and 3.5-fold, respectively). MMP-2 mRNA was highly expressed and not 
modulated by the oxygen percentage. The expression of MMP-9 mRNA remained unaffected 
and was at the limit of detection at both oxygen percentages (Figure 5.3A). 
 
Figure 5.3: Quantification of MMPs produced by HAC cultured at different oxygen percentages during 
the Phase I. (A) Real time reverse transcription-polymerase chain reaction analysis of the expression of MMP-
1, -2, -9, -13 mRNA by human articular chondrocytes (HAC) cultured in pellets at 19% and 5% O2. Levels are 
expressed as fold of difference from ribosomal 18S. (B) Quantification of MMP-1, -2, -9, -13 released in the 
culture medium. Levels are normalized to the amount of DNA measured in relative pellets. Values are mean ± 
SD of measurements obtained from three independent experiments. * = significantly different from the 19% O2. 
The protein levels of MMP-1, -2, -9, -13 were assessed in the supernatant of pellet cultures at the end of Phase I. 
Consistent with the mRNA results, the amounts of MMP-1 and -13 released were reduced in the pellets cultured 
at 5% O2 as compared to those cultured at 19% O2 (8.2- and 11.3-fold respectively). The protein expression 
levels of MMP-2 and -9 remained similar at the different oxygen percentages (Figure 5.3B). 
Chapter 5: The influence of various oxygen percentages on chondrocytes function 
 
112 
 
Effect of oxygen percentage on HAC anabolic and catabolic activity in pre-formed 
cartilaginous tissues 
We next investigated the influence of oxygen in anabolic (synthesis and accumulation of 
cartilaginous matrix proteins) and catabolic (MMPs expression, activity and degradation 
products) processes of pre-formed tissues. Pellets generated after two weeks of culture at 
19% O2 or 5% O2 (Phase I) were subsequently cultured up to an additional two weeks (Phase 
II) at the same or at interchanged oxygen percentages (Figure 5.1). 
 
Accumulation and synthesis of cartilaginous matrix proteins 
In agreement with the above described results, pellets cultured for four weeks (two weeks of 
Phase I and two weeks of Phase II) at 5% O2 were more strongly stained for Safranin O and 
type II collagen, and accumulated larger amounts of GAG (4.0-fold) as compared to those 
cultured for the same time at 19% O2 (Figure 5.4A, B, C). Reducing oxygen percentage 
during Phase II for pellets cultured at 19% during Phase I resulted in an improved quality of 
the cartilaginous tissues, as assessed by an increased accumulation of cartilaginous matrix 
positive for GAG and type II collagen (Figure 5.4A, B) and by a higher GAG content (3.3-
fold) (Figure 5.4C). Conversely, increasing oxygen percentage during Phase II for pellets 
cultured at 5% during Phase I resulted in a reduced accumulation of cartilaginous matrix 
(Figure 5.4A, B) and GAG content (1.9-fold) (Figure 5.4C). 
Results from the radiolabelling experiments indicated that similar amounts of total collagen 
and proteoglycan (that is, released + accumulated) were synthesized by pellets cultured for 18 
days (two weeks of Phase I and four days of Phase II) at the two oxygen percentages. 
However, as compared to 19% oxygen (Phase I and Phase II), the released fractions of these 
newly synthesized macromolecules by pellets cultured at 5% O2 (Phase I and Phase II) were 
markedly and statistically significantly lower (2.0- and 2.9-fold respectively for collagen and 
proteoglycan), while the accumulated fractions were higher (2.1- and 6.6-fold respectively for 
collagen and proteoglycan). Consistent with the biochemical results, the culture at 5% O2 
during Phase II of tissues pre-formed at 19% O2 during Phase I resulted in an augmented 
synthesis of collagen and proteoglycan (respectively by 2.7- and 1.4-fold). In particular, the 
increased synthesis of the newly synthesized macromolecules was mainly reflected by an 
augmented accumulation (up to 5.9-fold). 
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Figure 5.4: Anabolic response of HAC to different oxygen percentages during differentiation Phase I and 
II. (A - B) Safranin O and type II collagen stainings of representative tissues generated by human articular 
chondrocytes (HAC) cultured in pellets for two weeks (Phase I) at 19% (I and II) or 5% (III and IV) oxygen and 
further cultured for two additionally weeks (Phase II) at 19% (I and III) or 5% (II and IV) oxygen. Bar = 100 
μm. (C) Quantification of glycosaminoglycans (GAG) accumulated in pellets cultured as described in (A - B) 
normalized to the amount of DNA. (D - E) Amounts of newly synthesized collagen (D) and proteoglycan (E) 
measured in pellets cultured for 18 days (two weeks of Phase I and four days of Phase II). The upper and lower 
parts of the columns represent the released and accumulated fractions respectively. Values are mean ± SD of 
measurements obtained from two independent experiments. * = significantly different from the group cultured 
with the same oxygen percentage in Phase I but with different oxygen tension in Phase II; ° = significantly 
different from the group cultured entirely at 19% O2; a = accumulated, r = released. 
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Instead, the culture at 19% O2 during Phase II of tissues pre-formed at 5% O2 during Phase I 
differently modulated the synthesis of the two extracellular matrix molecules: while a 
decreased accumulation (2.3-fold) and an increased released (2.6-fold) was measured for 
collagen, only a reduction of the accumulated fraction was demonstrated for proteoglycan 
(8.6-fold) (Figure 4D, E). 
 
MMPs production and activity 
Pellets cultured for four weeks (two weeks of Phase I and two weeks of Phase II) at 5% O2 
released lower amounts of MMP-1 and -13 (6.1- and 10.1-fold respectively) as compared to 
those cultured for the same time at 19% O2. Culture at 5% O2 during Phase II of tissues pre-
formed at 19% O2 during Phase I resulted in reduced production of both MMPs, though only 
MMP-13 by statistically significant levels (by 1.8-fold). Instead, culture at 19% O2 during 
Phase II of pellets pre-formed at 5% O2 during Phase I resulted in increased release of both 
MMP-1 and MMP-13 (4.0- and 6.2-fold respectively) (Figure 5A, B). 
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Figure 5.5: Catabolic response of HAC to different oxygen percentages during differentiation Phase I and 
II. (A - B) Quantification of MMP-1 (A) and MMP-13 (B) released in the medium by human articular 
chondrocytes (HAC) cultured in pellets for four weeks (two weeks of Phase I and two weeks of Phase II). 
Levels are normalized to the amount of DNA measured in relative pellets. Values are mean ± SD of 
measurements obtained from two independent experiments. * = significantly different from the group cultured 
with the same oxygen percentage in Phase I but with different oxygen tension in Phase II; ° = significantly 
different from the group cultured entirely at 19% O2 (Phase I and Phase II). (C) Immunohistochemical detection 
of type II collagen fragments of pellets cultured under conditions described in (A - B). Bar = 100 μm. 
 
In order to assess whether the observed increased production of MMPs corresponded to an 
increased proteinase activity, pellets cultured for a total of four weeks at the different oxygen 
percentages were assessed immunohistochemically to detect the presence of type II collagen 
C-telopeptides, derived by MMP-1 and -13 collagenolytic activity [33]. Analyses indicated 
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that only the pellets formed at 5% O2 during Phase I and subsequently cultured at 19% O2 
during Phase II were intensely stained for the type II collagen fragments (Figure 5.5C). 
 
Collagen fibril organization 
To determine whether increasing oxygen percentage during cultivation Phase II of tissues 
pre-formed at 5% O2 would change the structure and arrangement of the collagen fibril 
network, pellets were qualitatively and quantitatively assessed via EM. Images indicated that 
the collagen fibrils of pellets cultured at 5% O2 during Phase I and then for two weeks at 19% 
O2 during Phase II were less linear than those of pellets cultured for four weeks at 5% O2. 
Interestingly, a similar trend was also observed in the OA cartilage as compared to healthy 
cartilage samples (Figure 5.6A, B). In pellets, the collagen network was comprised of single 
fibrils with diameters ranging from 20 to 30 nm. In healthy adult cartilage, the network 
contained bundled and twisted collagen fibrils three- to four-fold larger in diameter. 
Quantitative image analysis indicated that increasing the oxygen percentage during Phase II 
resulted in a significant reduction of persistence length as well as bending ratio (47.9% and 
10.5% respectively). Interestingly, both parameters were higher in healthy as compared to 
OA tissues (30.0% and 6.6% respectively for persistence length and bending ratio). 
Considerable decrease in persistence length and bending ratio would indicate softening and 
gradual deterioration of cartilage physiological function [39]. 
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Figure 5.6: SEM images and structural analysis of extracellular collagen-fibrils from engineered, healthy 
and osteoarthritic cartilage samples. Representative scanning electron microscopy (SEM) images of (A) 
tissues generated by culturing human articular chondrocytes in pellets for four weeks (two weeks of Phase I and 
two weeks of Phase II) or (B) native human tissue biopsies from healthy or osteoarthritic (OA) cartilage. (C) 
Persistence length and (D) bending ratio assessment of the extracellular fibril network of engineered and native 
tissues. * = significant different from 19% O2; ° = significant different from OA tissues. 
 
Response to low oxygen under CdCl2-treatment 
To determine whether the observed pro-anabolic and anti-catabolic effects of low oxygen 
percentage are mediated by HIF-1α, HAC from three donors were pre-cultured in pellets 
during Phase I at 19% O2. During the subsequent culture Phase II, the pre-cultured pellets 
were maintained at 19% O2 or exposed to 5% O2, with or without treatment with CdCl2 for six 
hours or three days (Figure 5.7A). Following culture at low oxygen percentage, type II 
collagen mRNA was up-regulated to a higher extent after six hours (up to 33.0-fold; Figure 
5.7B) than after three days (data not shown), while MMP-1 mRNA was down-regulated to a 
higher extent after three days (up to 65.5-fold; Figure 5.7C) than after six hours (data not 
shown). Supplementation of CdCl2 during this culture phase almost abrogated the 
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aforementioned low O2-mediated effects, so that the expression of type II collagen and MMP-
1 mRNA reached levels comparable to those of cells cultured at 19% O2 for the 
corresponding times (Figure 5.7B, C). 
 
Figure 5.7: Effects inhibition of HIF-1α on anabolic and catabolic gene regulation at low oxygen 
percentage. (A) Experimental design: human articular chondrocytes from three donors were cultured as pellets 
in chondrogenic medium (ChM) at 19% O2 (Phase I) and subsequently maintained at the same oxygen 
percentage or exposed to 5% O2 in the absence or presence of 5 μM CdCl2 for six hours or three days (Phase II). 
Real time reverse transcription-polymerase chain reaction analysis of type II collagen mRNA expression after 
six hours (B) and of MMP-1 mRNA expression after three days (C). Levels are expressed as fold of difference 
from ribosomal 18S. Values for each donor are mean ± SD of measurements obtained from three independent 
pellets. 
 
5.5 Discussion  
 
In this study we found that culture at low, more physiological (5%) oxygen percentage has a 
dual role in HAC metabolism, namely to enhance the proteoglycan and collagen synthesis 
and at the same time to reduce the activity of two key catabolic enzymes involved in cartilage 
breakdown (that is, MMP-1 and MMP-13). As a consequence, HAC exposure to 19% oxygen 
reduced the de novo formation of cartilage tissue and induced degradation of pre-deposited 
collagen fibrils, leading to structural features similar to those found in osteoarthritic tissue. 
Interestingly, HAC appeared to be highly sensitive to the oxygen percentage applied during 
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differentiation culture in pellets, but not during expansion in monolayers. The anti-anabolic 
and pro-catabolic effects mediated by low oxygen percentage were HIF1α-dependent, as 
assessed by specific inhibition of this factor by CdCl2 treatment. 
The application of 5% oxygen percentage during the HAC monolayer expansion did not 
influence the proliferation rate and chondrogenic capacity of HAC. This is in contrast with 
results reported by Egli et al. [7], indicating that bovine articular chondrocytes expanded 
under hypoxic conditions generated tissues with higher amounts of cartilaginous matrix as 
compared to those expanded under normoxic conditions. The discrepancy between our results 
and those generated by Egli et al. [7] can be related to the different type of cells used (human 
vs bovine), the stage of cell de-differentiation (second passaged vs first passaged cells) and/or 
the specific oxygen percentage tested (5% vs 1.5%). Indeed, HAC culture at lower than 5% 
oxygen during expansion may lead to a benefit in their redifferentiation capacity, and remains 
to be investigated. 
The influence of oxygen percentage during the de-novo tissue formation was evaluated by 
culturing HAC in micromass pellets, a model commonly used to investigate in vitro cartilage 
development. Our results indicate that the application of 5% as compared to 19% oxygen 
percentage critically enhanced the chondrogenic capacity of HAC, as assessed by a greater 
accumulation of GAG and type II collagen. Similar responses to reduced oxygen percentage 
have been reported [9] using human nasal chondrocytes statically cultured in pellets for three 
days and subsequently transferred to a dynamic bioreactor system. We also investigated 
whether culture of chondrocytes at low oxygen percentage modulated the production of 
specific metalloproteinases involved in the degradation of extracellular matrix proteins. We 
observed that the expression of MMP-1 and MMP-13, both at mRNA and protein levels, was 
reduced in cells cultured at 5% as compared to 19% oxygen. Interestingly, MMP-1 (or 
collagenase-1) and/or MMP-13 (or collagenase-3) are among the enzymes expressed by 
human chondrocytes in degenerative pathologies of cartilage, namely osteoarthritis and 
rheumatoid arthritis [41] and are thus thought to play a critical role in cartilage destruction. In 
particular, it has been shown that both MMPs are involved in the initial phase of type II 
collagen breakdown [42,43], and MMP-13 is the collagenase with highest affinity for type II 
collagen [44]. However, the expression of other MMPs or degradative enzymes (for example, 
aggrecanases) not included in our study might also be regulated by culture at low oxygen 
tension. 
Our results prompted us to hypothesize that different oxygen percentages could regulate not 
only cartilage generation, but also its further maturation and stability. We thus exposed 
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tissues formed at the different oxygen percentages for two weeks (Phase I) to interchanged 
oxygen percentages in a subsequent culture phase (Phase II). Results obtained from the 
radiolabelling experiments indicated that the exposure of tissues to 5% oxygen during Phase 
II induced higher synthesis and accumulation of collagen and proteoglycan. It remains to be 
assessed whether low oxygen percentages also enhance expression of molecules involved in 
stabilization of the newly synthesized extracellular matrix components (for example, decorin, 
fibromodulin, link protein, type IX collagen) [45]. Importantly, the presence of type II 
collagen cleavage products, indicative of MMP activity, was immunohistochemically 
detected [33] only in the pellets pre-formed at 5% oxygen (Phase I) and subsequently 
cultured for additional two weeks at 19% oxygen (Phase II). These results, together with the 
observed enhanced expression of MMP-1 and -13 at 19% oxygen, strongly indicate a direct 
involvement of oxygen in regulating the MMP-mediated breakdown of cartilaginous tissues. 
The result that pellets entirely cultured at 19% O2 negatively stained for type II collagen 
fragments could be explained by the insufficient accumulation of the MMP substrate (that is, 
type II collagen) during the initial cultivation Phase I. 
The presence of type II collagen fragments correlated well with the branched/tangled 
collagen fibril organization and decreased values of bending ratio and persistence length in 
pellets exposed to 19% oxygen. This could possibly result from an increased enzymatic 
cleavage of the extracellular matrix molecules by specific MMPs. Conclusively, increased 
activity of catabolic enzymes is affecting the collagen fibril network that exhibits lower 
values of bending ratio and persistence length. Based on this correlation, both parameters 
could potentially represent valuable markers for determining the degree of collagen 
deterioration. Exposure of cartilage tissues formed at physiological oxygen percentages to 
higher oxygen levels resembled degradation events occurring during the progression of OA, 
where, following initial pathologic events, the normal oxygen gradients break down [6]. 
Therefore, our tissue engineering model would be instrumental to investigation of the 
evolution of cartilage damage following alteration of the oxygen levels and to assess the 
effect of possible therapeutic targets. 
The observed pro-anabolic and anti-catabolic effects of low oxygen culture were mediated by 
the hypoxia inducible signaling pathway, since reduction of the oxygen percentage did not 
regulate type II collagen and MMP-1 mRNA expression in the presence of the HIF-1α 
inhibitor cadmium chloride (CdCl2) [28]. While the importance of HIF-1α in modulating the 
expression/synthesis of cartilage-specific genes was recently addressed [28-46], the 
involvement of this factor in the oxygen-dependent modulation of catabolic genes, recently 
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reported for porcine pulmonary artery endothelial and smooth muscle cells [47], has not been 
previously postulated for HAC. 
 
5.6 Conclusions 
 
The present study demonstrates that low oxygen percentage applied during the differentiation 
phases of human articular chondrocyte culture enhances cell biosynthetic activity as well as 
reduces the activity of catabolic enzymes known to play key roles in the breakdown of 
cartilage matrix during degenerative pathologies. These findings indicate that regulation of 
oxygen percentages during in vitro culture could be used to improve the generation of 
functional cartilage substitutes, and thus prompt the development of tools enabling accurate 
control of oxygen levels for tissues of clinically relevant size [48]. Moreover, modulation of 
oxygen tension in cultured HAC may be used as a tool to model and study in vitro 
pathophysiological events occurring in osteoarthritis. Finally, following such investigations, 
the identification of innovative strategies to maintain local in vivo oxygen percentages to 
defined levels could represent a powerful tool for preventing the progression of degenerative 
cartilage diseases. 
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6.1 Abstract  
Cells move by actively remodeling a dense network of protein filaments. Here we analyze the 
force response of various filaments in a simplified experimental setup, where single filaments 
are moved with an atomic-force microscope (AFM) tip against surface friction, with the AFM 
operating in the torsional mode. Our experimental findings are well explained within a simple 
model based on Newtonian mechanics: we observe force plateaus, which are the signature of 
the sequential stretching of single repeat units, followed ultimately by deformation of the 
whole polymer shape. 
 
6.2 Introduction, results, discussion  
During tissue morphogenesis, mammalian cells move within an extracellular matrix 
composed of cross-linked collagen fibrils [1]. The traction force enabling cell movement, 
typically several nN per µm
2
 [2], is localized at discrete sites called focal adhesions [3]. Such 
localized forces are sufficient to induce major rearrangements of the fibrillar elements [1,4]. 
These substrate changes are readily observable by atomic-force microscopy (AFM) of 
fibroblasts moving on glass coated with collagen fibrils: single fibrils appear bent, oriented in 
the direction of the closest cell adhesion site [5]. Here we develop a simplified experimental 
setup for analyzing the frictional and elastic response of fibrils: A single protein filament or 
fibril is adsorbed on a substrate and moved by an AFM tip perpendicular to the AFM 
cantilever axis and at a constant velocity [6]. The AFM cantilever twists substantially, 
generating force and moving the polymer forward [7]. Past studies addressing polymers on 
surfaces have classified adsorption regimes and behavior in the standard AFM geometry 
(retracting from the surface) [8]. Here we concentrate on the essential physics of 
manipulating molecules in the interfacial plane. We choose as model systems desmin 
intermediate filaments (IFs) and collagen fibrils; both adopt roughly linear configurations 
when adsorbed on mica (Fig. 6.1). The response of these two types of filaments to the AFM 
were qualitatively different: collagen fibrils were moved by the cantilever, elongated and bent 
into a continuous cusp shape [Fig. 6.1(b), arrow 1], while desmin filaments (and bundles of 
collagen fibrils) were locally stretched until broken, see Fig. 6.1(b) (arrow 2) and Fig. 6.2(a). 
These elongations imply that fibrils were locally stretched up to 3.5 and 1.3 times their 
original length, for desmin IFs and bundles of collagen fibrils, respectively. For both systems 
the stretching involved a few repeat units; however, for desmin this amounts to a length of 
~150 nm [Fig. 6.2(a)], whereas for the collagen bundles the deformed region was 
micrometers long [Fig. 6.1(b)]. To quantify these observations we show in Fig. 6.2(c) the 
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force versus cantilever displacement curves for a desmin filament. Such curves always show 
an initial linear region (in all of n = 60 experiments), a force plateau, and a subsequent 
nonlinear increase in force [7]. In some experiments we observed two consecutive force 
plateaus, as shown in Fig. 6.2(c). Similar force curves with multiple steps were also observed 
for desmin filaments reassembled from a one-to-one mixture of wild-type desmin and a point 
mutant D399Y [9]; see Fig. 6.2(d). Because the torsional force constant of the AFM tips had 
to be relatively large to sustain forces up to f ≈ 4 nN, the resulting force fluctuations  
δf = (kc kb T) 
½ ≈ 100 pN are substantial, and must be filtered from the raw data; here we 
accomplish this filtering using a running-average over 5 nm. The local stretching of filaments 
shown in Figs. 6.1 and 6.2 is an unexpected result considering their properties in solution. In 
solution fibrils appear rodlike on the µm scale, and these rodlike configurations are 
maintained during adsorption, as shown in Fig. 6.1(a). When stretched on the surface, 
however, these filaments form sharp ‘‘corners’’ and stretching continues in relatively straight 
subsegments [Fig. 1(a), arrow 2].  
 
 
Figure 6.1:. Manipulation of collagen fibrils adsorbed to mica, pretreated with 1 M MgCl2 and immersed in 
PBS. Panels (a) and (b) were imaged prior to and after manipulation, respectively. Arrowheads identify two 
manipulations yielding a bent fibril with a cusped shape (1) and a stretched and broken bundle of fibrils (2). 
 
This implies that fibrils behave structurally different under these conditions; here the shape of 
the molecule is dominated by tension, rather than by bending rigidity as for solvated fibrils. 
In order to quantify these observations, we model filaments on surfaces as single or 
continuous-multistate wormlike chains (WLCs) subject to surface friction and external force. 
The fact that the filaments can be ‘‘stretched’’ implies that they have an effective contour 
length Lc longer than the end-to-end length with which they are adsorbed to the surface (L0). 
Furthermore, because we are stretching a small number of repeat units, we must account for 
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the discreteness of the chain. To accomplish this we describe individual repeat units 
separately, using a WLC model for each segment. These separate WLCs are connected end-
to-end to form the complete filament. Here we will refer to the individual WLCs as ‘‘linkers’’ 
and to the composite chain as a ‘‘discretely connected wormlike chain’’ (DC-WLC) [see Fig. 
2(b)].  
 
 
Figure 6.2: (a) AFM image of single wild-type desmin filaments obtained after manipulation (adsorbed to mica 
and immersed in 25 mM Tris-HCl, 100 mM NaCl, pH 7.5). (b) Shape of a DC-WLC manipulated by a point 
probe at its middle for two cantilever displacements. (Dots represent beads and lines represent linkers.) 
Parameters: v = 50 nm/s (as in experiment), Lp = 0.4 nm, Lc = 3200 nm, L0 = 1000 nm, N = 25 beads, and N v =  
0.3 N s/m. (c) Force versus displacement curves corresponding to panel A. Theoretical fit (broken line): Lc = 
2200 nm, N = 20, others as in panel (b). (d) Force versus displacement curves of desmin filaments containing an 
equal amount of wild-type proteins and mutant D399Y proteins [9] with theoretical fits. Arrowheads indicate tip 
displacements corresponding to the shapes presented in panel (b). Parameters (dotted curve): as in panel B; 
broken curve: Lp = 2 nm, Lc = 1600 nm. 
 
To simplify the inclusion of friction within a Langevin approach, we couple these massless 
linkers using beads with the mass m of a filament repeat unit. (In practice the mass of the 
beads does not affect the results, as we are in the low Reynolds number limit.) This model is 
akin to the Rouse model, where we use WLC linkers instead of harmonic springs to account 
for the large effective extensibility of the chain (L0 < Lc). In summary, the filaments are 
modeled by N beads, connected by massless WLC linkers. The motion of the polymer is 
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controlled by the tension along the chain, the friction force on the molecule, and the force 
applied at some point along the chain by the AFM cantilever [see the inset of Fig. 6.3(a)]. For 
the tension on the ith linker we take the approximate force-extension relation of the WLC 
[10]: 
 
(1)  
 
 
 
where T is the temperature, Lb = Lc / N is the contour length between beads, and xi is the 
distance separating beads i and i + 1.  
 
 
Figure 1Theoretical and experimental models. (a) Shapes of a DC-WLC chain manipulated by a point probe. 
Parameters: Lp = 1 nm, Lc = 1200 nm, N = 100, N v = 1 Ns/m, others as in Fig. 2(b). Inset: Schematic of the 
DCWLC. (b) Force versus displacement curves for the same chain manipulated at its middle (solid line) and at 
one end (broken line). (c) AFM image of a collagen fibril after manipulation revealing a similar cusp shape. (d) 
A 12 cm long rubber band adsorbed to a glass plate coated with silicon grease (Corning) and manipulated at an 
average velocity of 3 mm/s. (e) Force versus displacement curves for two DC-WLC chains, with Lc = 1200 and 
2000 nm for solid, dashed curves, respectively. [N = 20 beads; other parameters as in panel (a).] 
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The polymer remains in contact with the substrate during the whole experiment, and the ith 
monomer experiences a viscous drag or friction force, linear in the velocity of each monomer 
bead fi
(f) 
= -v vi, where v is the friction coefficient and vi is the velocity of the ith bead. 
In addition, the AFM tip exerts a force at a specific site of the chain, e.g., in the middle or at 
one end, fi=a
(AFM)
=kc (vt – yi); here we take the force to be due to a harmonic cantilever 
moving at a constant velocity. These forces are inserted into the Langevin equations for the 
individual beads, with the cantilever fluctuations as the external noise. The shape of the 
polymer chain as a function of time is obtained as the average motion, equivalent to the 
solution of Newton’s equations. The role of the fluctuations will be studied elsewhere after 
appropriate measurements have been performed. In our model the chain has an overall 
contour length Lc and is adsorbed to the substrate with an end-to-end length L0 < Lc. Two 
cases are of interest: Lc ~ L0, corresponding to collagen fibrils [11] and Lc ~ 2–3L0, 
corresponding to desmin IFs [6]; this second case also encompasses other biopolymers such 
as DNA [12], and fibrin [13]. If the chain has a limited extension (L0 ~ Lc), or if the force 
necessary to extend the chain is small compared to the viscous drag vυ, then the chain 
segments in the vicinity of the moving point probe extend first [Fig. 6.3(a)]. This process 
continues until all segments are under tension and gives rise to a linear force versus 
displacement curve [Fig. 6.3(b), solid line]. After all segments have extended close to their 
limit, the whole chain is set in motion [Fig. 6.3(a)] and the force converges asymptotically to 
vυ. As expected, the force versus displacement curve depends on the position of the point 
probe along the polymers [Fig. 6.3(b), compare solid and broken lines]. The cusp shape of the 
chain is due to the incremental motion of chain segments nearest to the moving tip; this is 
observed both at the nano and macro scales, see Figs. 6.3(c) and 6.3(d). Indeed, we see the 
same cusped shape with rubber bands (mm scale) as with fibrils (µm scale). For quantitative 
agreement between the model and experimental data, the viscous drag coefficient v had to be 
between 10
-3
 and 10
-1
 Ns/m. Below 10
-3
 Ns/m the system is underdamped and strong 
oscillations occur; above 10
-1
 Ns/m the system is overdamped, and around 102 Ns/m the 
chain is stuck to the substrate. In order to relate the viscous drag coefficient to a bulk 
viscosity η, we use Stokes’s relation, v=6πηa, where a is the radius of the particle. This 
radius can take any value between 1 and 100 nm for biopolymers, so our range of v is 
equivalent to a bulk viscosity η between 103 and 107 Pa s, corresponding to peanut butter and 
pitch, respectively. Although the AFM experiments are performed in water (bulk viscosity 
10
-3
 Pa s), the binding of the protein filaments to the substrate ions gives rise to an extremely 
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viscous interface. These numbers compare well with estimates based on the thermal 
activation model by Briscoe and Evans [14,15] and also with estimates based on the 
Tomlinson model [16]. Because the equivalent viscosity is so high, the repeat units of the 
chain are stuck in position if no force is applied by the point probe. This is in agreement with 
the AFM experiments, where no evidence of relaxation was detectable long after a given 
manipulation [7]. Even though we are studying a dynamic process, the large viscosity 
imposes a near-equilibrium stretching of the chain, validating the use of Eq. (1) to estimate 
the tensions at the linkers’ ends. For desmin filaments the number of participating repeat 
units is small because each unit can extend to several times its original end-to-end length 
before the next repeat unit is affected. We can account for this in the model by setting N to a 
small number; in such a situation the stretching of individual repeat units is observable as 
steps in the force versus displacement curve, if the units are extensible enough [Fig. 6.3(e), 
compare Lc = 1200 nm and 2000 nm with 20 beads]. In addition, the deformation only affects 
the chain in the vicinity of the applied force, in stark contrast to the cusplike shape and in 
perfect agreement with experiment. (It should be noted that, when pulling in the center of a 
symmetric chain, one force step corresponds to two repeat units unfolding on opposite sides 
of the point probe.) So far, single force steps have been reported experimentally for desmin 
IFs [7] but not multiple ones. In these earlier experiments, the pieces of filament that were 
manipulated had an average length of only 80 ± 27 nm (n = 60) and the maximal tip 
displacement was on average 150 ± 41 nm (n = 60) [7]. Assuming in our model that each 
linker is 45–50 nm long and can extend to 160–180 nm maximum, the observation of more 
than one force step is indeed very unlikely. However, we did find, retrospectively, one force 
curve out of 60 measured in that study that displayed two force steps [7]. As further 
experimental evidence for the existence of multiple force steps in desmin filaments, we 
performed an additional n = 90 experiments on a population of desmin filaments reassembled 
from a one-to-one mixture in urea of wild-type desmin and a point mutant D399Y [9]. AFM 
measurements were performed exactly in the same conditions as wild-type desmin filaments 
[7]; the pieces of filament that were manipulated had an average length of 125 ± 37 nm (n ¼ 
90), and the maximal tip displacement was on average 215 ± 73 nm (n = 90). As predicted by 
our model, we found samples with multiple force steps, as previously presented in Fig. 
6.2(d). Such multiple steps were visible in a total of 11 out of n = 90 curves; even though 
each individual curve was distinct from the others, it was possible to fit each one by allowing 
variations in the number of beads N, the contour length of the linkers Lc, and the persistence 
length Lp. Since we have to change the chain parameters (N, Lc, Lp) to fit the experimental 
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data, desmin filaments cannot be well modeled by a single DC-WLC. This is due to the fact 
that desmin IFs have a hierarchical structure, with around 40 protein chains arranged in 
parallel in the cross-section of the filament [9]. The chains dimerize to form 45 nm long 
repeat units, which are double stranded α-helical coiled coils, and which can unfold upon 
stretching [17]. The unfolding of the coiled-coil essentially implies that the length of a repeat 
unit increases. Sliding between the chains can also occur, explaining the extreme extensibility 
of hese filaments [6]. Hence, the WLC linkers should be replaced by a more complex 
multistate polymer model. As a step in that direction we have implemented a continuous two-
state model for the linkers [18]: we describe the linker as a double stranded α-helical coiled 
coil, 40 nm in length, composed of 0.15 nm long units that can unfold to 0.38 nm. The coiled-
coil and unfolded polypeptides have persistence lengths of Lp1 = 25 nm [17] and Lp2 ¼ 0:4 
nm, respectively. We assume a Gibbs free energy difference between the two states of ΔV = 
250 meV and an interaction energy between the two states of 20 meV, with other parameters 
as in Fig. 6.2(b).  
 
 
Figure 6.4: (a) Comparison of the DC-WLC fit of Fig. 2(d) (dotted line) with a two-state model fit (broken line) 
for the same experimental curve. (b) equilibrium stretching curves for the two models: two-state (solid line) and 
DC-WLC (dotted line). 
 
In Fig. 6.4(a) we show again the experimental data and corresponding fit from Fig. 6.2(d) 
(green dotted curve), which we compare with a fit from the two-state model [6.4(a), blue 
dashed curve]. Note that our original fit based on the simpler DC-WLC model is already 
within the experimental error; additional experiments are necessary to resolve the difference 
between the two fits. Nevertheless, this example demonstrates the potential of the techniques 
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presented in this paper: Based on the fit parameters we can calculate the expected equilibrium 
force-extension relations in the standard AFM geometry (one end of the molecule tethered to 
the AFM tip); see Fig. 6.4(b). With the continuous two-state model we obtain a plateau force 
at 230 pN; this value is higher than the plateau forces measured for a single myosin coiled-
coil [17], but desmin IFs consist, in cross-section, of around 20 coiled-coils wrapped around 
each other. Interestingly, assuming a filament diameter of 10 nm, the stress at the plateau is 
expected to be on the order of 3MPa, which is in excellent agreement with published values 
for macroscopic bundles of IFs [19].  
 
6.3 Conclusion 
In summary, AFM manipulation of protein filaments at solid-liquid interfaces yields 
information about their mechanical properties relevant for the understanding of cell motion. 
In this study the AFM is moved perpendicularly to its axis: torsional forces balance frictional 
and mechanical forces between the AFM tip and the molecule and surface. The mechanical 
properties of the stretched molecule are still visible in this geometry, and we obverse the 
sequential unfolding of single repeat units as force plateaus. Differences in the mechanical 
response for different filaments can be traced back to their characteristics, namely, their 
contour length, their persistence length, and their friction coefficient. We demonstrate these 
features within a simple mechanical model, which is sufficient to understand the current 
experimental data.  
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Micro- and nanomechanical analysis of articular cartilage by indentation-type atomic 
force microscopy – validation with a gel-microfiber composite 
Standard methods used for assessing the properties of cartilage (e.g. histology, biochemistry 
etc.) provide valuable information about the concentration and zonal distribution of the 
specific components, but not about mechanical properties. Established mechanical testing 
techniques offer quantitative measurements of bulk mechanical properties that are not 
sufficient for the tissue engineering and diagnostic purposes where precise and detailed 
measurements are needed. Over the last decade, AFM has been established as a powerful tool 
for imaging, measuring and manipulating soft biological matter at all relevant scales of cell 
and tissue architecture [63, 64]. In 2004 Martin Stolz and Ueli Aebi [65] have shown that 
articular cartilage exhibits a scale dependent dynamic stiffness and opened new scientific 
horizons in understanding molecular origins of cartilage mechanics. In the later work they  
also reported that mechanical changes during development of OA in human cartilage and 
animal model  were only detectable at the nanometer scale, but not at the micrometer- to 
millimeter scales [2, 3, 4].  However, in all previous studies there was no clear indication 
provided about the origin of bimodal stiffness distribution. Therefore, the main focus of our 
study was to find the direct correlation between specific components of articular cartilage and 
resulting peaks in stiffness distribution at the nanometer and micrometer scale. We 
discriminated contribution of PGs to cartilage stiffness by modulating ionic strength of the 
PGs structure which resulted in a shift of the “softer” peak while “stiffer” peak remained 
unchanged. This was the direct proof that the lower stiffness peak is mainly due to the PGs 
contribution while higher peak is corresponding to the collagen behavior. By reproducing 
bimodal distribution on the gel-microfiber composite comprised of PEG fibres embedded in 
the agarose gel we obtained a further confirmation of our hypothesis. In addition, we were 
able to correlate extensive crossliniking bonds between collagen fibrils with much higher 
bulk stiffness of the native cartilage when compared  to the gel-microfiber composite where 
crosslinking was not formed. Similarly we measured much higher stiffness for PGs integrated 
in native cartilage comparing to stiffness obtained on the extracted PGs by Ortiz et. al [66]. 
Finally, results obtained in this study, document a high analytical potential of nanoscale 
assessment (Figure 7.1) of cartilage. Our future efforts will be focused on the detection of the 
early onset of the OA by measuring mechanical properties of cartilage and parallel correlate 
them with accumulation of potential biochemical markers (PGs, lubricin fragments and 
specific neoepitope like VDIPEN). 
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A) B) C)  
Figure 7.1 AFM image of native cartilage obtained with (A) micrometer sized tip diameter ~ 10µm, (B) 
sub-micrometer sized tip diameter ~ 0.9 µm, and (C) nanometer sized tip diameter ~ 20nm. 
 
Sliding Motion Improves Surface Properties of Engineered Cartilage: Evaluation by 
Friction Force and Indentation-Type Atomic Force Microscopy 
For treatment of cartilage defects it is of crucial importance to design and generate 
engineered cartilage with biochemical and biomechanical properties similar to authentic 
articular cartilage. The structure and mechanical properties of the superficial zone in AC play 
a critical role in frictionless gliding and weight bearing of the joints. However, surface 
characteristics are often either not addressed enough or completely ignored. Boundary 
lubrication has an important role in cartilage tribology and is primarily defined by the lubricin 
molecule. Use of the bioreactor system that stimulates cells with dynamic compression and 
sliding surface motion similar to natural joint movement enhanced  lubricin synthesis and its 
accumulation on the surface. However, distinct properties of generated cartilage (too soft and 
small immature tissue) prevent to probe it with robust, standard friction testing devices. This 
has motivated us to introduce a friction force AFM method that overcomes these issues and 
provides accurate measurements of the boundary friction. Results confirmed our hypothesis 
that samples stimulated both axially and vertically produced the highest amounts of lubricin 
and exhibited the lowest friction. .Our findings demonstrate that mechanical stimulation 
similar to joint articulation resulted in superior cartilage surface properties and underlines the 
importance of a biomechanical stimulus similar to physiological articulation for the (re-
)generation and maintenance of a functional AC surface. In addition, we propose the 
quantitative AFM-based analysis of graft material as a pre-requisite for evaluating the 
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functionality of engineered articular cartilage surfaces. Our future investigation will aim at 
studying the role of lubricin in the early onset of the OA.  
Articular cartilage repair by genetically modified bone marrow aspirate in sheep 
In this work we have systematically explored a novel, gene therapy based treatment for 
repairing cartilage defects. Such single-step procedure involves use of therapeutic gene 
transfer to stimulate chondrogenesis of mesenchymal progenitors harvested from the bone 
marrow. The motivation for using this approach comes from the need to surmount complex 
and time consuming ex vivo tissue engineering protocols. Obtained results show that 
mesenchymal progenitor’s transduced with potent chondorgenic factor (TGF-β1) exhibit 
properties close to the native cartilage. Moreover, histological and biochemical parameters 
were correlated with the mechanical measurements both at the nanometer and micrometer 
scale. For example, higher collagen I content in GFP samples correspond to the highest 
stiffness value. This difference was clearly detected at the nanometer scale as the unimodal 
stiffness distribution (see Chapter 2) resulting from very dense collagen network and 
relatively low PG concentration. Importantly, with mechanical characterization of the native 
healthy cartilage we obtained detailed mechanical profile which needs to be achieved in order 
to generate optimally functional cartilage. As the next step it will be of high interest to 
monitor the stiffness profile of cartilage grafts where multiple genes will be used 
simultaneously in modulating chondrogenesis.  
 
Anabolic and catabolic responses of human articular chondrocytes to varying oxygen 
percentages 
Oxygen is widely recognized as a significant factor in chondrocytes metabolism. Aim of this 
study was to investigate the effect of physiological (hypoxic) oxygen culture condition on 
chondrocytes in tissue formation and degradation activity. Moreover, we examined the 
structural organization and mechanics of collagen fibrils synthesized in both hypoxic and 
normoxic oxygen conditions and made further comparison with the collagen extracted from 
healthy and OA cartilage.  Interestingly, hypoxic conditions applied in the specific phase of 
chondrocytes differentiation strongly enhanced biosynthetic activity and suppressed 
degradation processes. In contrast, normoxic oxygen condition, almost identically to OA 
cartilage, stimulated degradation of the collagen network and formation of tangled collagen 
fibrils with very low stiffness properties. Striking similarity between tissue engineered 
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cartilage cultured under normoxic conditions and OA cartilage could provide a good ex vivo 
model for studying pathophysiological processes in OA. We will further use this model 
together with the state of the art collagen manipulation setup (Chapter 5) to gain more insight 
into the mechanical behavior of individual collagen fibrils under different anabolic and 
catabolic conditions.  
Stretching, unfolding, and deforming protein filaments adsorbed at solid-liquid 
interfaces using the tip of an atomic-force microscope 
Mechanical properties of collagen molecules at different levels of their assembly could play a 
role in the overall mechanical properties of cartilage. Moreover, collagen fibrils are forming 
dense meshwork in the extracellular matrix and thus have a significant impact on the 
chondrocytes migration. However, mechanical properties of collagen fibrils have only 
received attention in the last few years due to limitations in available techniques to examine 
them. In our study we present experimental and theoretical data on the stretching and 
unfolding of collagen and desmin intermediate filaments adsorbed to artificial surfaces. AFM 
manipulation on a surface immersed in liquid is relatively new and has previously defied 
quantitative analysis. By showing that the results of AFM experiments can be explained in 
terms of simple theoretical arguments, we make these experiments quantitative. Furthermore, 
our experimental results, combined with our theoretical model, demonstrate for the first time 
the forced stick-slip stretching of a single desmin filament and collagen fibril. Moreover, 
lateral manipulation allowed us to test filaments and fibrils trough the entire scale of 
deformation up to the breaking point which is a real advantage over other similar techniques. 
Another advantage is that by using AFM for we were able to test microfibrils of small 
diameter (~50nm) in near physiological buffer condition while most of the studies so far were 
preformed on air-dried fibrils. Due to above mentioned advantages our setup will be further 
used for studying mechanical properties of collagen fibrils extracted from cartilage at 
different stages of OA progression and from tissue engineered constructs and models for OA 
(Chapter 4).  
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Conclusions 
 
The work presented in this thesis provides new insights into the mechanical behavior of the 
cartilaginous tissue and its main components at the nanometer scale. In particularly, we 
identified the key contributors to bimodal distribution. Lower stiffness peak was associated 
with PGs and higher with collagen contribution. Defined assessment of the PGs mechanics 
opened further possibilities to investigate their behavior in the native, diseased and 
engineered cartilage. Moreover, we identified lubricin as a critical molecule for tribological 
properties of cartilage. To achieve this we had to extend the operation range of the AFM, by 
developing the friction force mode for boundary lubrication assessment of tissue engineered 
cartilage. Then small collagen microfibrils (diameter ~50nm) caught our intention since they 
were present basically in all types of engineered cartilage but also in OA cartilage. Hence we 
wanted to measure their contribution to the cartilage mechanical properties. However, 
techniques that were available did not offer an accurate and reproducible characterization of 
collagen fibrils. Most of them were not even optimized for work in liquid environment which 
is prerequisite for measuring biological materials. All those issues motivated us to overcome 
obstacles and to develop lateral manipulation by AFM. With the new setup we are able for 
the first time to measure collagen molecules in near physiological conditions and test the full 
range of collagen deformation up to the breaking point.  
 
Perspectives 
 
Today, our AFM setup is optimally tuned for accurate assessment of compression, tension 
and friction properties of cartilage and similar soft tissues. New scientific data presented in 
this thesis underscore the importance of nanomechanics for cartilage function and are 
currently explored for early diagnostic of OA and quality control of tissue engineered 
cartilage. Now we focus on assessing the friction interactions between solid and soft matrix 
components, collagen and PGs respectively. Energy dissipated during this process is still not 
measured. Although based on theoretical approximation it accounts for substantial 
contribution in cartilage function and could provide significant contribution towards the 
better understanding of cartilage mechanics at the molecular level. Next the exploration of 
collagen nanomechanics at different stage of fibrillogenesis and assembly (e.g rope like, 
parallel, tangle) will have significant impact not only for cartilage tissue engineering but also 
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for synthetic material application. Last but not least, we want to focus on implementing 
hardware and software advancements for the development of easy to use and reliable tissue 
diagnostic tool. By combining state-of-the-art AFM techniques with cutting edge modelling 
and simulation in applied “Patient-specific MultiScale Modeling and Simulation of 
OSTEOarthritis” proposal (EU project – FP7), we want to provide a holistic understanding of 
the causes of OA across the different biological scales. This is expected to bring important 
answers and solutions towards the treatment and prevention of OA in the future. 
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